<!DOCTYPE html>
<html lang="en" dir="ltr" class="client-nojs">
<head>
<meta charset="UTF-8" />
<title>Doxorubicin - Wikipedia, the free encyclopedia</title>
<meta name="generator" content="MediaWiki 1.26wmf13" />
<link rel="alternate" href="android-app://org.wikipedia/http/en.m.wikipedia.org/wiki/Doxorubicin" />
<link rel="alternate" type="application/x-wiki" title="Edit this page" href="/w/index.php?title=Doxorubicin&amp;action=edit" />
<link rel="edit" title="Edit this page" href="/w/index.php?title=Doxorubicin&amp;action=edit" />
<link rel="apple-touch-icon" href="/static/apple-touch/wikipedia.png" />
<link rel="shortcut icon" href="/static/favicon/wikipedia.ico" />
<link rel="search" type="application/opensearchdescription+xml" href="/w/opensearch_desc.php" title="Wikipedia (en)" />
<link rel="EditURI" type="application/rsd+xml" href="//en.wikipedia.org/w/api.php?action=rsd" />
<link rel="alternate" hreflang="x-default" href="/wiki/Doxorubicin" />
<link rel="copyright" href="//creativecommons.org/licenses/by-sa/3.0/" />
<link rel="alternate" type="application/atom+xml" title="Wikipedia Atom feed" href="/w/index.php?title=Special:RecentChanges&amp;feed=atom" />
<link rel="canonical" href="https://en.wikipedia.org/wiki/Doxorubicin" />
<link rel="stylesheet" href="//en.wikipedia.org/w/load.php?debug=false&amp;lang=en&amp;modules=ext.uls.nojs%7Cext.visualEditor.viewPageTarget.noscript%7Cext.wikihiero%7Cmediawiki.legacy.commonPrint%2Cshared%7Cmediawiki.sectionAnchor%7Cmediawiki.skinning.interface%7Cmediawiki.ui.button%7Cskins.vector.styles%7Cwikibase.client.init&amp;only=styles&amp;skin=vector&amp;*" />
<meta name="ResourceLoaderDynamicStyles" content="" />
<link rel="stylesheet" href="//en.wikipedia.org/w/load.php?debug=false&amp;lang=en&amp;modules=site&amp;only=styles&amp;skin=vector&amp;*" />
<style>a:lang(ar),a:lang(kk-arab),a:lang(mzn),a:lang(ps),a:lang(ur){text-decoration:none}
/* cache key: global:resourceloader:filter:minify-css:7:de1ab5287c9076b96eedd3f97a84a7b6 */</style>
<script src="//en.wikipedia.org/w/load.php?debug=false&amp;lang=en&amp;modules=startup&amp;only=scripts&amp;skin=vector&amp;*"></script>
<script>if(window.mw){
mw.config.set({"wgCanonicalNamespace":"","wgCanonicalSpecialPageName":false,"wgNamespaceNumber":0,"wgPageName":"Doxorubicin","wgTitle":"Doxorubicin","wgCurRevisionId":669020725,"wgRevisionId":669020725,"wgArticleId":1802881,"wgIsArticle":true,"wgIsRedirect":false,"wgAction":"view","wgUserName":null,"wgUserGroups":["*"],"wgCategories":["CS1 maint: Explicit use of et al.","Articles with changed EBI identifier","Chemical articles having calculated molecular weight overwritten","Articles with changed InChI identifier","Drugboxes which contain changes to verified fields","Articles that use a Medicine navs subtemplate","Good articles","Wikipedia articles with GND identifiers","Anthracyclines","Anthraquinone glycosides","Topoisomerase inhibitors","IARC Group 2A carcinogens","Embryotoxins","Teratogens"],"wgBreakFrames":false,"wgPageContentLanguage":"en","wgPageContentModel":"wikitext","wgSeparatorTransformTable":["",""],"wgDigitTransformTable":["",""],"wgDefaultDateFormat":"dmy","wgMonthNames":["","January","February","March","April","May","June","July","August","September","October","November","December"],"wgMonthNamesShort":["","Jan","Feb","Mar","Apr","May","Jun","Jul","Aug","Sep","Oct","Nov","Dec"],"wgRelevantPageName":"Doxorubicin","wgRelevantArticleId":1802881,"wgIsProbablyEditable":true,"wgRestrictionEdit":[],"wgRestrictionMove":[],"wgRedirectedFrom":"Doxorubicin-induced_cardiomyopathy","wgMediaViewerOnClick":true,"wgMediaViewerEnabledByDefault":true,"wikilove-recipient":"","wikilove-anon":0,"wgPoweredByHHVM":true,"wgWikiEditorEnabledModules":{"toolbar":true,"dialogs":true,"hidesig":true,"preview":false,"publish":false},"wgBetaFeaturesFeatures":[],"wgVisualEditor":{"pageLanguageCode":"en","pageLanguageDir":"ltr","usePageImages":true,"usePageDescriptions":true},"wgGatherShouldShowTutorial":true,"wgGatherPageImageThumbnail":"//upload.wikimedia.org/wikipedia/commons/thumb/0/0c/Doxorubicin2DCSD.svg/100px-Doxorubicin2DCSD.svg.png","wgULSAcceptLanguageList":[],"wgULSCurrentAutonym":"English","wgFlaggedRevsParams":{"tags":{"status":{"levels":1,"quality":2,"pristine":3}}},"wgStableRevisionId":null,"wgCategoryTreePageCategoryOptions":"{\"mode\":0,\"hideprefix\":20,\"showcount\":true,\"namespaces\":false}","wgNoticeProject":"wikipedia","wgInternalRedirectTargetUrl":"/wiki/Doxorubicin","wgWikibaseItemId":"Q18936"});
}</script><script>if(window.mw){
mw.loader.implement("user.options",function($,jQuery){mw.user.options.set({"variant":"en"});});
/* cache key: global:resourceloader:filter:minify-js:7:b2706269305541eba923c165462b22c4 */
}</script>
<script>if(window.mw){
mw.loader.implement("user.tokens",function($,jQuery){mw.user.tokens.set({"editToken":"+\\","patrolToken":"+\\","watchToken":"+\\"});});
}</script>
<script>if(window.mw){
mw.loader.load(["mediawiki.action.view.redirect","mediawiki.page.startup","mediawiki.legacy.wikibits","mediawiki.legacy.ajax","ext.centralauth.centralautologin","mmv.head","ext.imageMetrics.head","ext.visualEditor.viewPageTarget.init","ext.uls.init","ext.uls.interface","ext.centralNotice.bannerController","skins.vector.js"]);
}</script>
<link rel="dns-prefetch" href="//meta.wikimedia.org" />
<!--[if lt IE 7]><style type="text/css">body{behavior:url("/w/static/1.26wmf13/skins/Vector/csshover.min.htc")}</style><![endif]-->
</head>
<body class="mediawiki ltr sitedir-ltr ns-0 ns-subject page-Doxorubicin skin-vector action-view">
		<div id="mw-page-base" class="noprint"></div>
		<div id="mw-head-base" class="noprint"></div>
		<div id="content" class="mw-body" role="main">
			<a id="top"></a>

							<div id="siteNotice"><!-- CentralNotice --></div>
						<div class="mw-indicators">
<div id="mw-indicator-good-star" class="mw-indicator"><a href="/wiki/Wikipedia:Good_articles" title="This is a good article. Click here for more information."><img alt="This is a good article. Click here for more information." src="//upload.wikimedia.org/wikipedia/en/thumb/9/94/Symbol_support_vote.svg/19px-Symbol_support_vote.svg.png" width="19" height="20" srcset="//upload.wikimedia.org/wikipedia/en/thumb/9/94/Symbol_support_vote.svg/29px-Symbol_support_vote.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/9/94/Symbol_support_vote.svg/39px-Symbol_support_vote.svg.png 2x" data-file-width="180" data-file-height="185" /></a></div>
</div>
			<h1 id="firstHeading" class="firstHeading" lang="en">Doxorubicin</h1>
									<div id="bodyContent" class="mw-body-content">
									<div id="siteSub">From Wikipedia, the free encyclopedia</div>
								<div id="contentSub"><span class="mw-redirectedfrom">  (Redirected from <a href="/w/index.php?title=Doxorubicin-induced_cardiomyopathy&amp;redirect=no" title="Doxorubicin-induced cardiomyopathy">Doxorubicin-induced cardiomyopathy</a>)</span></div>
												<div id="jump-to-nav" class="mw-jump">
					Jump to:					<a href="#mw-head">navigation</a>, 					<a href="#p-search">search</a>
				</div>
				<div id="mw-content-text" lang="en" dir="ltr" class="mw-content-ltr"><table class="infobox" style="width:22em;border-spacing:2px;">
<caption>Doxorubicin</caption>
<tr>
<td colspan="2" style="text-align:center"><a href="/wiki/File:Doxorubicin2DCSD.svg" class="image"><img alt="Doxorubicin2DCSD.svg" src="//upload.wikimedia.org/wikipedia/commons/thumb/0/0c/Doxorubicin2DCSD.svg/220px-Doxorubicin2DCSD.svg.png" width="220" height="178" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/0/0c/Doxorubicin2DCSD.svg/330px-Doxorubicin2DCSD.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/0/0c/Doxorubicin2DCSD.svg/440px-Doxorubicin2DCSD.svg.png 2x" data-file-width="1300" data-file-height="1052" /></a></td>
</tr>
<tr>
<td colspan="2" style="text-align:center"><a href="/wiki/File:Doxorubicin_3D_ball.png" class="image"><img alt="Doxorubicin 3D ball.png" src="//upload.wikimedia.org/wikipedia/commons/thumb/c/cd/Doxorubicin_3D_ball.png/220px-Doxorubicin_3D_ball.png" width="220" height="164" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/c/cd/Doxorubicin_3D_ball.png/330px-Doxorubicin_3D_ball.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/c/cd/Doxorubicin_3D_ball.png/440px-Doxorubicin_3D_ball.png 2x" data-file-width="2000" data-file-height="1490" /></a></td>
</tr>
<tr>
<th colspan="2" style="text-align:center;background:#ddd">Systematic (<a href="/wiki/International_Union_of_Pure_and_Applied_Chemistry_nomenclature" title="International Union of Pure and Applied Chemistry nomenclature" class="mw-redirect">IUPAC</a>) name</th>
</tr>
<tr>
<td colspan="2" style="text-align:center">
<div style="word-wrap:break-word; text-align:left; padding-left:1.5em; text-indent:-1.5em; font-size:11px">(7S,9S)-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione</div>
</td>
</tr>
<tr>
<th colspan="2" style="text-align:center;background:#ddd">Clinical data</th>
</tr>
<tr>
<th scope="row" style="padding:0.1em 0;line-height:1.2em;"><a href="/wiki/Trade_name" title="Trade name">Trade names</a></th>
<td>Adriamycin</td>
</tr>
<tr>
<th scope="row" style="padding:0.1em 0;line-height:1.2em;"><a href="/wiki/American_Society_of_Health-System_Pharmacists" title="American Society of Health-System Pharmacists">AHFS</a>/<a href="/wiki/Drugs.com" title="Drugs.com">Drugs.com</a></th>
<td><span class="reflink plainlinks nourlexpansion"><a rel="nofollow" class="external text" href="http://www.drugs.com/monograph/doxorubicin-hydrochloride.html">monograph</a></span></td>
</tr>
<tr>
<th scope="row" style="padding:0.1em 0;line-height:1.2em;"><a href="/wiki/MedlinePlus" title="MedlinePlus">MedlinePlus</a></th>
<td><span class="reflink plainlinks nourlexpansion"><a rel="nofollow" class="external text" href="http://www.nlm.nih.gov/medlineplus/druginfo/meds/a682221.html">a682221</a></span></td>
</tr>
<tr>
<th scope="row" style="padding:0.1em 0;line-height:1.2em;"><a href="/wiki/Pregnancy_category" title="Pregnancy category">Pregnancy<br />
category</a></th>
<td>
<div class="plainlist">
<ul>
<li><small><abbr title="Australia">AU</abbr>:</small> <a href="/wiki/Pregnancy_category#Australia" title="Pregnancy category">D</a></li>
<li><small><abbr title="United States">US</abbr>:</small> <a href="/wiki/Pregnancy_category#United_States" title="Pregnancy category">D</a> (Evidence of risk)</li>
</ul>
</div>
</td>
</tr>
<tr>
<th scope="row" style="padding:0.1em 0;line-height:1.2em;"><a href="/wiki/Regulation_of_therapeutic_goods" title="Regulation of therapeutic goods">Legal status</a></th>
<td>
<div class="plainlist">
<ul>
<li><small><abbr title="Australia">AU</abbr>:</small> <a href="/wiki/Standard_for_the_Uniform_Scheduling_of_Drugs_and_Poisons#Schedule_4_Prescription_Only_Medicine" title="Standard for the Uniform Scheduling of Drugs and Poisons" class="mw-redirect">Prescription Only (S4)</a></li>
<li><small><abbr title="Canada">CA</abbr></small>: <a href="/wiki/Prescription_drug" title="Prescription drug"><span class="Unicode">℞</span>-only</a></li>
<li><small><abbr title="United Kingdom">UK</abbr>:</small> <a href="/wiki/Prescription_drug" title="Prescription drug">Prescription-only</a> (POM)</li>
<li><small><abbr title="United States">US</abbr>:</small> <a href="/wiki/Prescription_drug" title="Prescription drug"><span class="Unicode">℞</span>-only</a></li>
</ul>
</div>
</td>
</tr>
<tr>
<th scope="row" style="padding:0.1em 0;line-height:1.2em;"><a href="/wiki/Route_of_administration" title="Route of administration">Routes of<br />
administration</a></th>
<td><a href="/wiki/Intravenous_therapy" title="Intravenous therapy">Intravenous</a>, intravesical</td>
</tr>
<tr>
<th colspan="2" style="text-align:center;background:#ddd"><a href="/wiki/Pharmacokinetics" title="Pharmacokinetics">Pharmacokinetic</a> data</th>
</tr>
<tr>
<th scope="row" style="padding:0.1em 0; line-height:1.2em;"><a href="/wiki/Bioavailability" title="Bioavailability">Bioavailability</a></th>
<td>5% (Oral)</td>
</tr>
<tr>
<th scope="row" style="padding:0.1em 0; line-height:1.2em;"><a href="/wiki/Plasma_protein_binding" title="Plasma protein binding">Protein binding</a></th>
<td>75%<sup id="cite_ref-MSR_1-0" class="reference"><a href="#cite_note-MSR-1"><span>[</span>1<span>]</span></a></sup></td>
</tr>
<tr>
<th scope="row" style="padding:0.1em 0; line-height:1.2em;"><a href="/wiki/Drug_metabolism" title="Drug metabolism">Metabolism</a></th>
<td>Hepatic</td>
</tr>
<tr>
<th scope="row" style="padding:0.1em 0; line-height:1.2em;"><a href="/wiki/Biological_half-life" title="Biological half-life">Biological half-life</a></th>
<td>Triphasic; 12 minutes, 3.3 hours, 30 hours. Mean: 1-3 hours<sup id="cite_ref-MSR_1-1" class="reference"><a href="#cite_note-MSR-1"><span>[</span>1<span>]</span></a></sup><sup id="cite_ref-MD_2-0" class="reference"><a href="#cite_note-MD-2"><span>[</span>2<span>]</span></a></sup></td>
</tr>
<tr>
<th scope="row" style="padding:0.1em 0; line-height:1.2em;"><a href="/wiki/Excretion" title="Excretion">Excretion</a></th>
<td>Urine (5-12%), faeces (40-50%)<sup id="cite_ref-MSR_1-2" class="reference"><a href="#cite_note-MSR-1"><span>[</span>1<span>]</span></a></sup></td>
</tr>
<tr>
<th colspan="2" style="text-align:center;background:#ddd">Identifiers</th>
</tr>
<tr>
<th scope="row" style="padding:0.1em 0;line-height:1.2em;"><a href="/wiki/CAS_Registry_Number" title="CAS Registry Number">CAS Registry Number</a></th>
<td><span class="reflink plainlinks nourlexpansion"><a rel="nofollow" class="external text" href="//www.nlm.nih.gov/cgi/mesh/2009/MB_cgi?term=23214-92-8&amp;rn=1">23214-92-8</a></span><sup>&#160;<img alt="Yes" src="//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/7px-Yes_check.svg.png" width="7" height="7" srcset="//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/11px-Yes_check.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/14px-Yes_check.svg.png 2x" data-file-width="600" data-file-height="600" /><span style="display:none">Y</span></sup></td>
</tr>
<tr>
<th scope="row" style="padding:0.1em 0;line-height:1.2em;"><a href="/wiki/Anatomical_Therapeutic_Chemical_Classification_System" title="Anatomical Therapeutic Chemical Classification System">ATC code</a></th>
<td><a href="/wiki/ATC_code_L01" title="ATC code L01">L01</a><span class="reflink plainlinks nourlexpansion"><a rel="nofollow" class="external text" href="http://www.whocc.no/atc_ddd_index/?code=L01DB01">DB01</a></span></td>
</tr>
<tr>
<th scope="row" style="padding:0.1em 0;line-height:1.2em;"><a href="/wiki/PubChem" title="PubChem">PubChem</a></th>
<td>CID: <span class="reflink plainlinks nourlexpansion"><a rel="nofollow" class="external text" href="//pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=31703">31703</a></span></td>
</tr>
<tr>
<th scope="row" style="padding:0.1em 0;line-height:1.2em;"><a href="/wiki/IUPHAR/BPS" title="IUPHAR/BPS" class="mw-redirect">IUPHAR/BPS</a></th>
<td><span class="reflink plainlinks nourlexpansion"><a rel="nofollow" class="external text" href="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7069">7069</a></span></td>
</tr>
<tr>
<th scope="row" style="padding:0.1em 0;line-height:1.2em;"><a href="/wiki/DrugBank" title="DrugBank">DrugBank</a></th>
<td><span class="reflink plainlinks nourlexpansion"><a rel="nofollow" class="external text" href="http://www.drugbank.ca/drugs/DB00997">DB00997</a></span><sup>&#160;<img alt="Yes" src="//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/7px-Yes_check.svg.png" width="7" height="7" srcset="//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/11px-Yes_check.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/14px-Yes_check.svg.png 2x" data-file-width="600" data-file-height="600" /><span style="display:none">Y</span></sup></td>
</tr>
<tr>
<th scope="row" style="padding:0.1em 0;line-height:1.2em;"><a href="/wiki/ChemSpider" title="ChemSpider">ChemSpider</a></th>
<td><span class="reflink plainlinks nourlexpansion"><a rel="nofollow" class="external text" href="http://www.chemspider.com/Chemical-Structure.29400.html">29400</a></span><sup>&#160;<img alt="Yes" src="//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/7px-Yes_check.svg.png" width="7" height="7" srcset="//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/11px-Yes_check.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/14px-Yes_check.svg.png 2x" data-file-width="600" data-file-height="600" /><span style="display:none">Y</span></sup></td>
</tr>
<tr>
<th scope="row" style="padding:0.1em 0;line-height:1.2em;"><a href="/wiki/Unique_Ingredient_Identifier" title="Unique Ingredient Identifier">UNII</a></th>
<td><span class="reflink plainlinks nourlexpansion"><a rel="nofollow" class="external text" href="http://fdasis.nlm.nih.gov/srs/srsdirect.jsp?regno=80168379AG">80168379AG</a></span><sup>&#160;<img alt="Yes" src="//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/7px-Yes_check.svg.png" width="7" height="7" srcset="//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/11px-Yes_check.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/14px-Yes_check.svg.png 2x" data-file-width="600" data-file-height="600" /><span style="display:none">Y</span></sup></td>
</tr>
<tr>
<th scope="row" style="padding:0.1em 0;line-height:1.2em;"><a href="/wiki/KEGG" title="KEGG">KEGG</a></th>
<td><span class="reflink plainlinks nourlexpansion"><a rel="nofollow" class="external text" href="http://www.kegg.jp/entry/D03899">D03899</a></span><sup>&#160;<img alt="Yes" src="//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/7px-Yes_check.svg.png" width="7" height="7" srcset="//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/11px-Yes_check.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/14px-Yes_check.svg.png 2x" data-file-width="600" data-file-height="600" /><span style="display:none">Y</span></sup></td>
</tr>
<tr>
<th scope="row" style="padding:0.1em 0;line-height:1.2em;"><a href="/wiki/ChEBI" title="ChEBI">ChEBI</a></th>
<td><span class="reflink plainlinks nourlexpansion"><a rel="nofollow" class="external text" href="https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:28748">CHEBI:28748</a></span><sup>&#160;<img alt="Yes" src="//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/7px-Yes_check.svg.png" width="7" height="7" srcset="//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/11px-Yes_check.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/14px-Yes_check.svg.png 2x" data-file-width="600" data-file-height="600" /><span style="display:none">Y</span></sup></td>
</tr>
<tr>
<th scope="row" style="padding:0.1em 0;line-height:1.2em;"><a href="/wiki/ChEMBL" title="ChEMBL">ChEMBL</a></th>
<td><span class="reflink plainlinks nourlexpansion"><a rel="nofollow" class="external text" href="https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/CHEMBL53463">CHEMBL53463</a></span><sup>&#160;<img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/a/a2/X_mark.svg/7px-X_mark.svg.png" width="7" height="8" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/a/a2/X_mark.svg/11px-X_mark.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/a/a2/X_mark.svg/14px-X_mark.svg.png 2x" data-file-width="525" data-file-height="600" /><span style="display:none">N</span></sup></td>
</tr>
<tr>
<th colspan="2" style="text-align:center;background:#ddd">Chemical data</th>
</tr>
<tr>
<th scope="row" style="padding:0.1em 0; line-height:1.2em;--&gt;"><a href="/wiki/Chemical_formula" title="Chemical formula">Formula</a></th>
<td><a href="/wiki/Carbon" title="Carbon"><span style="color: rgb(000,000,000); font-weight: bold;">C</span></a><sub>27</sub><a href="/wiki/Hydrogen" title="Hydrogen"><span style="color: rgb(77,77,77); font-weight: bold;">H</span></a><sub>29</sub><a href="/wiki/Nitrogen" title="Nitrogen"><span style="color: rgb(0,0,128); font-weight: bold;">N</span></a><a href="/wiki/Oxygen" title="Oxygen"><span style="color: rgb(116,35,35); font-weight: bold;">O</span></a><sub>11</sub></td>
</tr>
<tr>
<th scope="row" style="padding:0.1em 0; line-height:1.2em;--&gt;"><a href="/wiki/Molecular_mass" title="Molecular mass">Molecular mass</a></th>
<td>543.52 <a href="/wiki/Gram" title="Gram">g</a>/<a href="/wiki/Mole_(unit)" title="Mole (unit)">mol</a></td>
</tr>
<tr>
<td colspan="2" style="text-align:center">
<div class="NavFrame collapsed" style="border: none; padding: 0;">
<div class="NavHead" style="font-size: 105%; background: transparent; text-align: left;"><a href="/wiki/Simplified_molecular_input_line_entry_specification" title="Simplified molecular input line entry specification" class="mw-redirect">SMILES</a></div>
<ul class="NavContent" style="list-style: none none; margin-left: 0; word-break:break-all; text-align:left; padding-left:1.5em; font-size: 105%; margin-top: 0; margin-bottom: 0; line-height: inherit;">
<li style="line-height: inherit; margin: 0">
<div style="word-wrap:break-word; text-indent:-1.5em">C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](Cc3c2c(c4c(c3O)C(=O)c5cccc(c5C4=O)OC)O)(C(=O)CO)O)N)O</div>
</li>
</ul>
</div>
</td>
</tr>
<tr>
<td colspan="2" style="text-align:center">
<div class="NavFrame collapsed" style="border: none; padding: 0;">
<div class="NavHead" style="font-size: 105%; background: transparent; text-align: left;"><a href="/wiki/International_Chemical_Identifier" title="International Chemical Identifier">InChI</a></div>
<ul class="NavContent" style="list-style: none none; margin-left: 0; word-break:break-all; text-align:left; padding-left:1.5em; font-size: 105%; margin-top: 0; margin-bottom: 0; line-height: inherit;">
<li style="line-height: inherit; margin: 0">
<div style="word-wrap:break-word; text-indent:-1.5em">InChI=1S/C27H29NO11/c1-10-22(31)13(28)6-17(38-10)39-15-8-27 (36,16(30)9-29)7-12-19(15)26(35)21-20(24(12)33)23 (32)11-4-3-5-14(37-2)18(11)25(21)34/h3-5,10,13,15, 17,22,29,31,33,35-36H,6-9,28H2,1-2H3/t10-,13-,15-,17-,22+,27-/m0/s1<sup>&#160;<img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/a/a2/X_mark.svg/7px-X_mark.svg.png" width="7" height="8" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/a/a2/X_mark.svg/11px-X_mark.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/a/a2/X_mark.svg/14px-X_mark.svg.png 2x" data-file-width="525" data-file-height="600" /><span style="display:none">N</span></sup></div>
</li>
<li style="line-height: inherit; margin: 0">
<div style="word-wrap:break-word; text-indent:-1.5em">Key:AOJJSUZBOXZQNB-TZSSRYMLSA-N<sup>&#160;<img alt="Yes" src="//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/7px-Yes_check.svg.png" width="7" height="7" srcset="//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/11px-Yes_check.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/14px-Yes_check.svg.png 2x" data-file-width="600" data-file-height="600" /><span style="display:none">Y</span></sup></div>
</li>
</ul>
</div>
</td>
</tr>
<tr>
<th colspan="2" style="text-align:center;background:#ddd">&#160;<img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/a/a2/X_mark.svg/14px-X_mark.svg.png" width="14" height="16" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/a/a2/X_mark.svg/21px-X_mark.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/a/a2/X_mark.svg/28px-X_mark.svg.png 2x" data-file-width="525" data-file-height="600" /><span style="display:none">N</span>&#160;<a href="/wiki/Wikipedia:WikiProject_Chemicals/Chembox_validation" title="Wikipedia:WikiProject Chemicals/Chembox validation">(what is this?)</a>&#160;&#160;<span class="reflink plainlinks nourlexpansion"><a class="external text" href="//en.wikipedia.org/w/index.php?title=Special:ComparePages&amp;rev1=458446335&amp;page2=Doxorubicin">(verify)</a></span></th>
</tr>
</table>
<p><b>Doxorubicin</b> <span class="nowrap"><span class="IPA nopopups"><a href="/wiki/Help:IPA_for_English" title="Help:IPA for English">/<span style="border-bottom:1px dotted"><span title="/ˌ/ secondary stress follows">ˌ</span><span title="'d' in 'dye'">d</span><span title="/ɒ/ short 'o' in 'body'">ɒ</span><span title="'k' in 'kind'">k</span><span title="'s' in 'sigh'">s</span><span title="/ə/ 'a' in 'about'">ə</span><span title="/ˈ/ primary stress follows">ˈ</span><span title="'r' in 'rye'">r</span><span title="/uː/ long 'oo' in 'food'">uː</span><span title="'b' in 'buy'">b</span><span title="/ɨ/ 'e' in 'roses'">ɨ</span><span title="'s' in 'sigh'">s</span><span title="/ɪ/ short 'i' in 'bid'">ɪ</span><span title="'n' in 'no'">n</span></span>/</a></span></span> (<a href="/wiki/International_Nonproprietary_Name" title="International Nonproprietary Name">INN</a>, <a href="/wiki/Australian_Approved_Name" title="Australian Approved Name">AAN</a>, <a href="/wiki/British_Approved_Name" title="British Approved Name">BAN</a>, <a href="/wiki/United_States_Adopted_Name" title="United States Adopted Name">USAN</a>; trade name <b>Adriamycin</b>; pegylated liposomal form trade name <b>Doxil</b> or <b>Caelyx</b>; nonpegylated liposomal form trade name <b>Myocet</b>), also known as <b>hydroxydaunorubicin</b> and <b>hydroxydaunomycin</b>, is a <a href="/wiki/Pharmaceutical" title="Pharmaceutical" class="mw-redirect">drug</a> used in cancer <a href="/wiki/Chemotherapy" title="Chemotherapy">chemotherapy</a> and derived by chemical <a href="/wiki/Semisynthesis" title="Semisynthesis">semisynthesis</a> from a bacterial species.<sup id="cite_ref-MD_2-1" class="reference"><a href="#cite_note-MD-2"><span>[</span>2<span>]</span></a></sup> It is an <a href="/wiki/Anthracycline" title="Anthracycline">anthracycline</a> <a href="/wiki/Chemotherapy#Cytotoxic_antibiotics" title="Chemotherapy">antitumor antibiotic</a> (note: in this context, this does not mean it is used to treat bacterial infections) closely related to the <a href="/wiki/Natural_product" title="Natural product">natural product</a> <a href="/wiki/Daunorubicin" title="Daunorubicin">daunomycin</a> and like all anthracyclines, it works by <a href="/wiki/Intercalation_(chemistry)" title="Intercalation (chemistry)">intercalating</a> DNA, with the most serious adverse effect being life-threatening <a href="/wiki/Cardiotoxicity" title="Cardiotoxicity">heart damage</a>. It is commonly used in the treatment of a wide range of <a href="/wiki/Cancer" title="Cancer">cancers</a>, including <a href="/wiki/Hematological_malignancy" title="Hematological malignancy" class="mw-redirect">hematological malignancies</a> (blood cancers, like <a href="/wiki/Leukaemia" title="Leukaemia" class="mw-redirect">leukaemia</a> and <a href="/wiki/Lymphoma" title="Lymphoma">lymphoma</a>), many types of <a href="/wiki/Carcinoma" title="Carcinoma">carcinoma</a> (solid tumours) and <a href="/wiki/Soft_tissue_sarcoma" title="Soft tissue sarcoma" class="mw-redirect">soft tissue sarcomas</a>.<sup id="cite_ref-mech_3-0" class="reference"><a href="#cite_note-mech-3"><span>[</span>3<span>]</span></a></sup> It is often used in <a href="/wiki/Combination_chemotherapy" title="Combination chemotherapy" class="mw-redirect">combination chemotherapy</a> as a component of <a href="/wiki/Chemotherapy_regimens#List_of_chemotherapy_regimen_acronyms" title="Chemotherapy regimens" class="mw-redirect">various chemotherapy regimens</a>.</p>
<p>Common adverse effects of doxorubicin include <a href="/wiki/Alopecia" title="Alopecia" class="mw-redirect">hair loss</a> (seen in most of those treated with the drug), <a href="/wiki/Myelosuppression" title="Myelosuppression" class="mw-redirect">myelosuppression</a> (a compromised ability of the body's bone marrow to produce new blood cells), nausea and vomiting (which are seen in roughly 30-90% of people treated with the drug), <a href="/wiki/Oral_mucositis" title="Oral mucositis" class="mw-redirect">oral mucositis</a>, <a href="/wiki/Oesophagitis" title="Oesophagitis" class="mw-redirect">oesophagitis</a>, <a href="/wiki/Diarrhoea" title="Diarrhoea" class="mw-redirect">diarrhoea</a>, skin reactions (including <a href="/wiki/Hand-foot_syndrome" title="Hand-foot syndrome" class="mw-redirect">hand-foot syndrome</a>) and localised <a href="/wiki/Erythema" title="Erythema">swelling and redness</a> along the vein in which the drug is delivered.<sup id="cite_ref-MD_2-2" class="reference"><a href="#cite_note-MD-2"><span>[</span>2<span>]</span></a></sup><sup id="cite_ref-AMH_4-0" class="reference"><a href="#cite_note-AMH-4"><span>[</span>4<span>]</span></a></sup> Less common, yet serious reactions include hypersensitivity reactions (including <a href="/wiki/Anaphylaxis" title="Anaphylaxis">anaphylaxis</a>), <a href="/wiki/Radiation_burn#Delayed_effects" title="Radiation burn">radiation recall</a>, heart damage and liver dysfunction.<sup id="cite_ref-AMH_4-1" class="reference"><a href="#cite_note-AMH-4"><span>[</span>4<span>]</span></a></sup></p>
<p>The drug is administered <a href="/wiki/Intravenous_therapy" title="Intravenous therapy">intravenously</a>, as the <a href="/wiki/Hydrochloride_salt" title="Hydrochloride salt" class="mw-redirect">hydrochloride salt</a>.<sup id="cite_ref-MD_2-3" class="reference"><a href="#cite_note-MD-2"><span>[</span>2<span>]</span></a></sup> It is sold under a number of different brand names, including <b>Adriamycin PFS</b>, <b>Adriamycin RDF</b>, or <b>Rubex</b>.<sup id="cite_ref-MD_2-4" class="reference"><a href="#cite_note-MD-2"><span>[</span>2<span>]</span></a></sup> Doxorubicin is photosensitive, and containers are often covered by an aluminum bag and/or brown wax paper to prevent light from affecting it.<sup id="cite_ref-MD_2-5" class="reference"><a href="#cite_note-MD-2"><span>[</span>2<span>]</span></a></sup> Doxorubicin is also available in <a href="/wiki/Liposome" title="Liposome">liposome</a>-encapsulated forms as Doxil (<a href="/wiki/PEGylation" title="PEGylation">pegylated</a> form), <a href="/wiki/Myocet" title="Myocet">Myocet</a> (nonpegylated form), and Caelyx, although these forms must also be given by intravenous injection.<sup id="cite_ref-MD_2-6" class="reference"><a href="#cite_note-MD-2"><span>[</span>2<span>]</span></a></sup></p>
<p></p>
<div id="toc" class="toc">
<div id="toctitle">
<h2>Contents</h2>
</div>
<ul>
<li class="toclevel-1 tocsection-1"><a href="#Medical_use"><span class="tocnumber">1</span> <span class="toctext">Medical use</span></a>
<ul>
<li class="toclevel-2 tocsection-2"><a href="#Doxil_shortage_in_the_US"><span class="tocnumber">1.1</span> <span class="toctext">Doxil shortage in the US</span></a></li>
<li class="toclevel-2 tocsection-3"><a href="#Experimental_therapy"><span class="tocnumber">1.2</span> <span class="toctext">Experimental therapy</span></a></li>
<li class="toclevel-2 tocsection-4"><a href="#Liposomal_formulations"><span class="tocnumber">1.3</span> <span class="toctext">Liposomal formulations</span></a></li>
<li class="toclevel-2 tocsection-5"><a href="#Experimental_models_of_cell_death_in_situ"><span class="tocnumber">1.4</span> <span class="toctext">Experimental models of cell death in situ</span></a></li>
<li class="toclevel-2 tocsection-6"><a href="#Antimalarial_activity"><span class="tocnumber">1.5</span> <span class="toctext">Antimalarial activity</span></a></li>
</ul>
</li>
<li class="toclevel-1 tocsection-7"><a href="#Adverse_effects"><span class="tocnumber">2</span> <span class="toctext">Adverse effects</span></a></li>
<li class="toclevel-1 tocsection-8"><a href="#Biosynthesis"><span class="tocnumber">3</span> <span class="toctext">Biosynthesis</span></a></li>
<li class="toclevel-1 tocsection-9"><a href="#Mechanism_of_action"><span class="tocnumber">4</span> <span class="toctext">Mechanism of action</span></a></li>
<li class="toclevel-1 tocsection-10"><a href="#History"><span class="tocnumber">5</span> <span class="toctext">History</span></a></li>
<li class="toclevel-1 tocsection-11"><a href="#See_also"><span class="tocnumber">6</span> <span class="toctext">See also</span></a></li>
<li class="toclevel-1 tocsection-12"><a href="#References"><span class="tocnumber">7</span> <span class="toctext">References</span></a></li>
<li class="toclevel-1 tocsection-13"><a href="#External_links"><span class="tocnumber">8</span> <span class="toctext">External links</span></a></li>
</ul>
</div>
<p></p>
<h2><span class="mw-headline" id="Medical_use">Medical use</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Doxorubicin&amp;action=edit&amp;section=1" title="Edit section: Medical use">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>Doxorubicin is commonly used to treat some <a href="/wiki/Leukemia" title="Leukemia">leukemias</a> and <a href="/wiki/Hodgkin%27s_lymphoma" title="Hodgkin's lymphoma">Hodgkin's lymphoma</a>, as well as cancers of the <a href="/wiki/Bladder_cancer" title="Bladder cancer">bladder</a>, <a href="/wiki/Breast_cancer" title="Breast cancer">breast</a>, <a href="/wiki/Stomach_cancer" title="Stomach cancer">stomach</a>, <a href="/wiki/Lung_cancer" title="Lung cancer">lung</a>, <a href="/wiki/Ovarian_cancer" title="Ovarian cancer">ovaries</a>, <a href="/wiki/Thyroid_cancer" title="Thyroid cancer">thyroid</a>, <a href="/wiki/Soft_tissue_sarcoma" title="Soft tissue sarcoma" class="mw-redirect">soft tissue sarcoma</a>, <a href="/wiki/Multiple_myeloma" title="Multiple myeloma">multiple myeloma</a>, and others.<sup id="cite_ref-MD_2-7" class="reference"><a href="#cite_note-MD-2"><span>[</span>2<span>]</span></a></sup><sup id="cite_ref-AMH_4-2" class="reference"><a href="#cite_note-AMH-4"><span>[</span>4<span>]</span></a></sup> Commonly used doxorubicin-containing <a href="/wiki/Chemotherapy_regimen" title="Chemotherapy regimen">regimens</a> are AC (Adriamycin, <a href="/wiki/Cyclophosphamide" title="Cyclophosphamide">cyclophosphamide</a>), TAC (<a href="/wiki/Taxotere" title="Taxotere" class="mw-redirect">Taxotere</a>, AC), <a href="/wiki/ABVD" title="ABVD">ABVD</a> (Adriamycin, <a href="/wiki/Bleomycin" title="Bleomycin">bleomycin</a>, <a href="/wiki/Vinblastine" title="Vinblastine">vinblastine</a>, <a href="/wiki/Dacarbazine" title="Dacarbazine">dacarbazine</a>), <a href="/wiki/BEACOPP" title="BEACOPP">BEACOPP</a>, <a href="/wiki/CHOP" title="CHOP">CHOP</a> (<a href="/wiki/Cyclophosphamide" title="Cyclophosphamide">cyclophosphamide</a>, hydroxydaunorubicin, <a href="/wiki/Vincristine" title="Vincristine">vincristine</a>, <a href="/wiki/Prednisone" title="Prednisone">prednisone</a>) and FAC (<a href="/wiki/5-fluorouracil" title="5-fluorouracil" class="mw-redirect">5-fluorouracil</a>, Adriamycin, <a href="/wiki/Cyclophosphamide" title="Cyclophosphamide">cyclophosphamide</a>).<sup id="cite_ref-MD_2-8" class="reference"><a href="#cite_note-MD-2"><span>[</span>2<span>]</span></a></sup></p>
<p>Doxil (see below) is used primarily for the treatment of ovarian cancer where the disease has progressed or recurred after <a href="/wiki/Cisplatin" title="Cisplatin">platinum-based chemotherapy</a>, or for the treatment of <a href="/wiki/AIDS" title="AIDS" class="mw-redirect">AIDS</a>-related <a href="/wiki/Kaposi%27s_sarcoma" title="Kaposi's sarcoma">Kaposi's sarcoma</a>.<sup id="cite_ref-Doxil_info_5-0" class="reference"><a href="#cite_note-Doxil_info-5"><span>[</span>5<span>]</span></a></sup></p>
<h3><span class="mw-headline" id="Doxil_shortage_in_the_US">Doxil shortage in the US</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Doxorubicin&amp;action=edit&amp;section=2" title="Edit section: Doxil shortage in the US">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>As of February 2014, Doxil was available for clinical use in limited supply.<sup id="cite_ref-6" class="reference"><a href="#cite_note-6"><span>[</span>6<span>]</span></a></sup> In 2011, Doxil became available only in very limited supply due to production problems with the third-party manufacturer. Johnson &amp; Johnson (JNJ), through its subsidiary Janssen Products, LP, had been receiving its Doxil supply from contract manufacturer Ben Venue Laboratories (located in Bedford, Ohio), a unit of <i>Boehringer Ingelheim GmbH</i> of Germany.<sup id="cite_ref-7" class="reference"><a href="#cite_note-7"><span>[</span>7<span>]</span></a></sup> The problems began when Ben Venue temporarily shut down their manufacturing facility due to quality control issues.<sup id="cite_ref-8" class="reference"><a href="#cite_note-8"><span>[</span>8<span>]</span></a></sup></p>
<p>In February 2012, to address the Doxil shortage, the US Food and Drug Administration (FDA) allowed for the temporary importation of Lipodox, which contains the same active ingredient as Doxil and is made by Sun Pharma Global FZE (Sun), a subsidiary of India's Sun Pharmaceutical Industries Ltd.<sup id="cite_ref-9" class="reference"><a href="#cite_note-9"><span>[</span>9<span>]</span></a></sup> The agency said it intends to continue allowing the importation of Lipodox until Sun has made enough generic Doxil to meet demand.<sup id="cite_ref-10" class="reference"><a href="#cite_note-10"><span>[</span>10<span>]</span></a></sup></p>
<p>The FDA approved the first generic version of Doxil, made by Sun, in February 2013. It will be available in 20 milligram and 50 milligram vials.<sup id="cite_ref-11" class="reference"><a href="#cite_note-11"><span>[</span>11<span>]</span></a></sup></p>
<h3><span class="mw-headline" id="Experimental_therapy">Experimental therapy</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Doxorubicin&amp;action=edit&amp;section=3" title="Edit section: Experimental therapy">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p><a href="/wiki/Combination_therapy" title="Combination therapy">Combination therapy</a> experiments with <a href="/wiki/Sirolimus" title="Sirolimus">sirolimus</a> (rapamycin) and doxorubicin have shown promise in treating <a href="/wiki/Akt" title="Akt" class="mw-redirect">Akt</a>-positive <a href="/wiki/Lymphoma" title="Lymphoma">lymphomas</a> in mice.<sup id="cite_ref-12" class="reference"><a href="#cite_note-12"><span>[</span>12<span>]</span></a></sup></p>
<p>Recent animal research coupling a <a href="/wiki/Murine" title="Murine" class="mw-redirect">murine</a> <a href="/wiki/Monoclonal_antibody" title="Monoclonal antibody">monoclonal antibody</a> with doxorubicin has created an <a href="/wiki/Immunoconjugate" title="Immunoconjugate">immunoconjugate</a> that was able to eliminate <a href="/wiki/HIV" title="HIV">HIV-1</a> infection in mice. Current treatment with <a href="/wiki/Antiretroviral_drug" title="Antiretroviral drug" class="mw-redirect">antiretroviral therapy</a> (ART) still leaves pockets of HIV within the host. The immunoconjugate could potentially provide a complementary treatment to ART to eradicate antigen-expressing <a href="/wiki/T_cell" title="T cell">T cells</a>.<sup id="cite_ref-13" class="reference"><a href="#cite_note-13"><span>[</span>13<span>]</span></a></sup></p>
<h3><span class="mw-headline" id="Liposomal_formulations">Liposomal formulations</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Doxorubicin&amp;action=edit&amp;section=4" title="Edit section: Liposomal formulations">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p><b>Doxil</b> (US) or <b>Caelyx</b> (ex-US) is a <a href="/wiki/Pegylated" title="Pegylated" class="mw-redirect">pegylated</a> (polyethylene glycol coated) <a href="/wiki/Liposome" title="Liposome">liposome</a>-encapsulated form of doxorubicin formerly made by <a href="/w/index.php?title=Ben_Venue_Laboratories&amp;action=edit&amp;redlink=1" class="new" title="Ben Venue Laboratories (page does not exist)">Ben Venue Laboratories</a> in the United States for <a href="/w/index.php?title=Janssen_Products,_LP&amp;action=edit&amp;redlink=1" class="new" title="Janssen Products, LP (page does not exist)">Janssen Products, LP</a>, a subsidiary of <a href="/wiki/Johnson_%26_Johnson" title="Johnson &amp; Johnson">Johnson &amp; Johnson</a>. It was developed to treat <a href="/wiki/Kaposi%27s_sarcoma" title="Kaposi's sarcoma">Kaposi's sarcoma</a>, an <a href="/wiki/AIDS" title="AIDS" class="mw-redirect">AIDS</a>-related cancer that causes lesions to grow under the skin, in the lining of the mouth, nose and throat, or in other organs. The <a href="/wiki/Polyethylene_glycol" title="Polyethylene glycol">polyethylene glycol</a> coating results in preferential concentration of Doxil in the skin. However, this also results in a side effect called <a href="/wiki/Palmar_plantar_erythrodysesthesia" title="Palmar plantar erythrodysesthesia" class="mw-redirect">palmar plantar erythrodysesthesia</a> (PPE), more commonly known as hand-foot syndrome. Following administration of Doxil, small amounts of the drug can leak from capillaries in the palms of the hands and soles of the feet. The result of this leakage is redness, tenderness, and peeling of the skin that can be uncomfortable and even painful. In clinical testing at 50&#160;mg/m<sup>2</sup> dosing every 4 weeks, 50.6% of patients treated with Doxil developed hand-foot syndrome. The prevalence of this side effect limits the Doxil dose that can be given as compared with doxorubicin in the same treatment regimen, thereby limiting potential substitution. Substitution would be desirable because liposome-encapsulated doxorubicin is less cardiotoxic than unencapsulated doxorubicin. Doxil is also approved by the FDA for treatment of ovarian cancer and multiple myeloma.<sup id="cite_ref-Macmillan_14-0" class="reference"><a href="#cite_note-Macmillan-14"><span>[</span>14<span>]</span></a></sup><sup id="cite_ref-15" class="reference"><a href="#cite_note-15"><span>[</span>15<span>]</span></a></sup></p>
<p><b><a href="/wiki/Myocet" title="Myocet">Myocet</a></b> is a non-pegylated liposomal doxorubicin made by <a href="/wiki/Enzon_Pharmaceuticals" title="Enzon Pharmaceuticals">Enzon Pharmaceuticals</a> for <a href="/wiki/Cephalon" title="Cephalon">Cephalon</a> in Europe and for Sopherion Therapeutics in the United States and Canada. Myocet is approved in Europe and Canada for treatment of metastatic breast cancer in combination with <a href="/wiki/Cyclophosphamide" title="Cyclophosphamide">cyclophosphamide</a>, but is not yet approved by the FDA for use in the United States. It is currently being studied by Sopherion Therapeutics in a pivotal phase III global registrational trial in concurrent combination with <a href="/wiki/Trastuzumab" title="Trastuzumab">trastuzumab</a> (Herceptin) and <a href="/wiki/Paclitaxel" title="Paclitaxel">paclitaxel</a> (Taxol) for treatment of <a href="/wiki/HER2" title="HER2" class="mw-redirect">HER2</a>-positive metastatic breast cancer. Unlike Doxil, the Myocet liposome does not have a polyethylene glycol coating, and therefore does not result in the same prevalence of hand-foot syndrome. The minimization of this side effect may allow for one for one substitution with doxorubicin in the same treatment regimen, thereby improving safety with no loss of efficacy. Like Doxil, the liposomal encapsulation of the doxorubicin limits the cardiotoxicity. In theory, by limiting the cardiotoxicity of doxorubicin through liposomal encapsulation, it can be used safely in concurrent combination with other cardiotoxic chemotherapy drugs, such as trastuzumab. There is an FDA black box warning that Herceptin cannot be used in concurrent combination with doxorubicin, only in sequential combination. Though concurrent combination of trastuzumab and doxorubicin in clinical studies found superior tumor response, the combination resulted in unacceptable cardiotoxicity, including risk of cardiac failure manifesting as <a href="/wiki/Congestive_heart_failure" title="Congestive heart failure" class="mw-redirect">congestive heart failure</a> (CHF). Published phase II study results have shown that Myocet, trastuzumab, and paclitaxel can safely be used concurrently without the cardiac risk, as measured by reduction in <a href="/wiki/LVEF" title="LVEF" class="mw-redirect">LVEF</a> function, while still achieving superior tumor response. This finding is the basis for the ongoing phase III trial for FDA approval.<sup id="cite_ref-Macmillan_14-1" class="reference"><a href="#cite_note-Macmillan-14"><span>[</span>14<span>]</span></a></sup></p>
<h3><span class="mw-headline" id="Experimental_models_of_cell_death_in_situ">Experimental models of cell death in situ</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Doxorubicin&amp;action=edit&amp;section=5" title="Edit section: Experimental models of cell death in situ">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>Intraperitoneal injection of doxorubicin in mice induces cell death of <a href="/wiki/Monocytes" title="Monocytes" class="mw-redirect">monocytes</a> and <a href="/wiki/Macrophage" title="Macrophage">macrophages</a>. The acute sterile inflammation in this model is characterized by rapid influx of neutrophils and increased levels of IL-6 and monocyte chemotactic protein-1. It was demonstrated that acute inflammation induced by doxorubicin is associated with apoptosis of monocytes/macrophages and that it is specific for doxorubicin, an immunogenic chemotherapeutic. Further, the inflammatory response is significantly reduced in mice deficient in myeloid differentiation primary response gene 88 (MyD88), TLR-2 or TLR-9. Importantly, a TLR-9 antagonist reduces the recruitment of neutrophils induced by doxorubicin. By contrast, the acute inflammatory response is not affected in TRIF(Lps2) mutant mice and in TLR-3, TLR-4 and caspase-1 knockout mice, which shows that the inflammasome does not have a major role in doxorubicin-induced acute inflammation.<sup id="cite_ref-16" class="reference"><a href="#cite_note-16"><span>[</span>16<span>]</span></a></sup></p>
<h3><span class="mw-headline" id="Antimalarial_activity">Antimalarial activity</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Doxorubicin&amp;action=edit&amp;section=6" title="Edit section: Antimalarial activity">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>There is some evidence for antimalarial activity for doxorubicin and similar compounds. In 2009, a compound similar in structure to doxorubicin was found to inhibit <a href="/wiki/Plasmepsin" title="Plasmepsin">plasmepsin</a> II, an enzyme unique to the malarial parasite <i><a href="/wiki/Plasmodium_falciparum" title="Plasmodium falciparum">Plasmodium falciparum</a></i>.<sup id="cite_ref-friedman_17-0" class="reference"><a href="#cite_note-friedman-17"><span>[</span>17<span>]</span></a></sup> The pharmaceutical company <a href="/wiki/GlaxoSmithKline" title="GlaxoSmithKline">GlaxoSmithKline</a> (GSK) later identified doxorubicin in a set of compounds that inhibit parasite growth <sup id="cite_ref-Gamo_18-0" class="reference"><a href="#cite_note-Gamo-18"><span>[</span>18<span>]</span></a></sup></p>
<h2><span class="mw-headline" id="Adverse_effects">Adverse effects</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Doxorubicin&amp;action=edit&amp;section=7" title="Edit section: Adverse effects">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>The most dangerous side effect of doxorubicin is <a href="/wiki/Cardiomyopathy" title="Cardiomyopathy">cardiomyopathy</a>, leading to <a href="/wiki/Congestive_heart_failure" title="Congestive heart failure" class="mw-redirect">congestive heart failure</a>. The incidence of this cardiomyopathy is dependent on its cumulative dose, with an incidence about 4% when the dose of doxorubicin is 500–550&#160;mg/m², 18% when the dose is 551–600&#160;mg/m² and 36% when the dose exceeds 600&#160;mg/m².<sup id="cite_ref-Chaterjee_19-0" class="reference"><a href="#cite_note-Chaterjee-19"><span>[</span>19<span>]</span></a></sup> There are several ways in which doxorubicin is believed to cause cardiomyopathy, including <a href="/wiki/Oxidative_stress" title="Oxidative stress">oxidative stress</a>, downregulation of genes for contractile proteins, and <a href="/wiki/P53" title="P53">p53</a> mediated <a href="/wiki/Apoptosis" title="Apoptosis">apoptosis</a>.<sup id="cite_ref-Chaterjee_19-1" class="reference"><a href="#cite_note-Chaterjee-19"><span>[</span>19<span>]</span></a></sup> The drug <a href="/wiki/Dexrazoxane" title="Dexrazoxane">dexrazoxane</a> is used to mitigate doxorubicin's cardiotoxicity.</p>
<p>Another common and potentially fatal complication of doxorubicin is <a href="/wiki/Typhlitis" title="Typhlitis" class="mw-redirect">typhlitis</a>, an acute life-threatening infection of the bowel.<sup id="cite_ref-20" class="reference"><a href="#cite_note-20"><span>[</span>20<span>]</span></a></sup></p>
<p>Additionally, some patients may develop <a href="/wiki/Palmar_plantar_erythrodysesthesia" title="Palmar plantar erythrodysesthesia" class="mw-redirect">PPE</a>, characterized by skin eruptions on the palms of the hand or soles of the feet, swelling, pain and <a href="/wiki/Erythema" title="Erythema">erythema</a>.<sup id="cite_ref-Doxil_info_5-1" class="reference"><a href="#cite_note-Doxil_info-5"><span>[</span>5<span>]</span></a></sup></p>
<p>Due to these side effects and its red color, doxorubicin has earned the nickname "red devil"<sup id="cite_ref-BlochCancerFaq_21-0" class="reference"><a href="#cite_note-BlochCancerFaq-21"><span>[</span>21<span>]</span></a></sup> or "red death."<sup id="cite_ref-22" class="reference"><a href="#cite_note-22"><span>[</span>22<span>]</span></a></sup></p>
<p>Chemotherapy can cause reactivation of <a href="/wiki/Hepatitis_B" title="Hepatitis B">hepatitis B</a>, and doxorubicin-containing regimens are no exception.<sup id="cite_ref-23" class="reference"><a href="#cite_note-23"><span>[</span>23<span>]</span></a></sup><sup id="cite_ref-24" class="reference"><a href="#cite_note-24"><span>[</span>24<span>]</span></a></sup></p>
<p>Doxorubicin and several chemotherapeutic drugs (including cyclophosphamide) cause dyspigmentation. Other groups of drugs that cause this problem include antimalarials, amiodarone, heavy metals (but not iron), tetracyclines, and antipsychotics.<sup id="cite_ref-25" class="reference"><a href="#cite_note-25"><span>[</span>25<span>]</span></a></sup></p>
<h2><span class="mw-headline" id="Biosynthesis">Biosynthesis</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Doxorubicin&amp;action=edit&amp;section=8" title="Edit section: Biosynthesis">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<div class="hatnote relarticle mainarticle">Main article: <a href="/wiki/Biosynthesis_of_doxorubicin" title="Biosynthesis of doxorubicin">Biosynthesis of doxorubicin</a></div>
<p>Doxorubicin (DXR) is a 14-<a href="/wiki/Hydroxylated" title="Hydroxylated" class="mw-redirect">hydroxylated</a> version of <a href="/wiki/Daunorubicin" title="Daunorubicin">daunorubicin</a>, the immediate precursor of DXR in its <a href="/wiki/Biosynthesis" title="Biosynthesis">biosynthetic</a> pathway. <a href="/wiki/Daunorubicin" title="Daunorubicin">Daunorubicin</a> is more abundantly found as a <a href="/wiki/Natural_product" title="Natural product">natural product</a> because it is produced by a number of different <a href="/wiki/Wild_type" title="Wild type">wild type</a> <a href="/wiki/Strain_(biology)" title="Strain (biology)">strains</a> of <i><a href="/wiki/Streptomyces" title="Streptomyces">Streptomyces</a></i>. In contrast, only one known non-<a href="/wiki/Wild_type" title="Wild type">wild type</a> <a href="/wiki/Species" title="Species">species</a>, <i><a href="/wiki/Streptomyces_peucetius" title="Streptomyces peucetius">Streptomyces peucetius</a></i> <a href="/wiki/Subspecies" title="Subspecies">subspecies</a> <i>cesius</i> ATCC 27952, was initially found to be capable of producing the more widely used doxorubicin.<sup id="cite_ref-pmid9864344_26-0" class="reference"><a href="#cite_note-pmid9864344-26"><span>[</span>26<span>]</span></a></sup> This strain was created by Arcamone et al. in 1969 by <a href="/wiki/Mutation" title="Mutation">mutating</a> a strain producing daunorubicin, but not DXR, at least in detectable quantities.<sup id="cite_ref-pmid5365804_27-0" class="reference"><a href="#cite_note-pmid5365804-27"><span>[</span>27<span>]</span></a></sup> Subsequently, Hutchinson's group showed that under special environmental conditions, or by the introduction of <a href="/wiki/Modifications_(genetics)" title="Modifications (genetics)">genetic modifications</a>, other strains of <i>Streptomyces</i> can produce doxorubicin.<sup id="cite_ref-pmid7828855_28-0" class="reference"><a href="#cite_note-pmid7828855-28"><span>[</span>28<span>]</span></a></sup> His group has also <a href="/wiki/Cloned" title="Cloned" class="mw-redirect">cloned</a> many of the <a href="/wiki/Genes" title="Genes" class="mw-redirect">genes</a> required for DXR production, although not all of them have been fully characterized. In 1996, Strohl's group discovered, isolated and characterized dox A, the <a href="/wiki/Gene" title="Gene">gene</a> encoding the <a href="/wiki/Enzyme" title="Enzyme">enzyme</a> that converts daunorubicin into DXR.<sup id="cite_ref-pmid8655530_29-0" class="reference"><a href="#cite_note-pmid8655530-29"><span>[</span>29<span>]</span></a></sup> By 1999, they produced recombinant dox A, a <a href="/wiki/Cytochrome_P450_oxidase" title="Cytochrome P450 oxidase" class="mw-redirect">cytochrome P450 oxidase</a>, and found that it <a href="/wiki/Catalyzes" title="Catalyzes" class="mw-redirect">catalyzes</a> multiple steps in DXR <a href="/wiki/Biosynthesis" title="Biosynthesis">biosynthesis</a>, including steps leading to daunorubicin.<sup id="cite_ref-pmid9864343_30-0" class="reference"><a href="#cite_note-pmid9864343-30"><span>[</span>30<span>]</span></a></sup> This was significant because it became clear that all daunorubicin-producing strains have the necessary <a href="/wiki/Genes" title="Genes" class="mw-redirect">genes</a> to produce DXR, the much more therapeutically important of the two. Hutchinson's group went on to develop methods to improve the yield of DXR, from the <a href="/wiki/Industrial_fermentation" title="Industrial fermentation">fermentation</a> process used in its commercial production, not only by introducing dox A encoding <a href="/wiki/Plasmids" title="Plasmids" class="mw-redirect">plasmids</a>, but also by introducing mutations to deactivate <a href="/wiki/Enzymes" title="Enzymes" class="mw-redirect">enzymes</a> that shunt DXR precursors to less useful products, for example baumycin-like <a href="/wiki/Glycosides" title="Glycosides" class="mw-redirect">glycosides</a>.<sup id="cite_ref-pmid9864344_26-1" class="reference"><a href="#cite_note-pmid9864344-26"><span>[</span>26<span>]</span></a></sup> Some triple mutants, that also <a href="/wiki/Gene_expression" title="Gene expression">over-expressed</a> dox A, were able to double the yield of DXR. This is of more than academic interest, because at that time DXR cost about $1.37 million per kg and current production in 1999 was 225&#160;kg per annum.<sup id="cite_ref-pmid10455495_31-0" class="reference"><a href="#cite_note-pmid10455495-31"><span>[</span>31<span>]</span></a></sup> More efficient production techniques have brought the price down to $1.1 million per kg for the non<a href="/wiki/Liposomal" title="Liposomal" class="mw-redirect">liposomal</a> formulation. Although DXR can be produced <a href="/wiki/Semisynthesis" title="Semisynthesis">semi-synthetically</a> from daunorubicin, the process involves <a href="/wiki/Electrophilic" title="Electrophilic" class="mw-redirect">electrophilic</a> <a href="/wiki/Bromination" title="Bromination" class="mw-redirect">bromination</a> and multiple steps, and the yield is poor.<sup id="cite_ref-pmid8022857_32-0" class="reference"><a href="#cite_note-pmid8022857-32"><span>[</span>32<span>]</span></a></sup> Since daunorubicin is produced by <a href="/wiki/Fermentation_(biochemistry)" title="Fermentation (biochemistry)" class="mw-redirect">fermentation</a>, it would be ideal if the <a href="/wiki/Bacteria" title="Bacteria">bacteria</a> could complete DXR synthesis more effectively.</p>
<h2><span class="mw-headline" id="Mechanism_of_action">Mechanism of action</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Doxorubicin&amp;action=edit&amp;section=9" title="Edit section: Mechanism of action">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<div class="thumb tright">
<div class="thumbinner" style="width:222px;"><a href="/wiki/File:Doxorubicin%E2%80%93DNA_complex_1D12.png" class="image"><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/e/ee/Doxorubicin%E2%80%93DNA_complex_1D12.png/220px-Doxorubicin%E2%80%93DNA_complex_1D12.png" width="220" height="232" class="thumbimage" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/e/ee/Doxorubicin%E2%80%93DNA_complex_1D12.png/330px-Doxorubicin%E2%80%93DNA_complex_1D12.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/e/ee/Doxorubicin%E2%80%93DNA_complex_1D12.png/440px-Doxorubicin%E2%80%93DNA_complex_1D12.png 2x" data-file-width="720" data-file-height="760" /></a>
<div class="thumbcaption">
<div class="magnify"><a href="/wiki/File:Doxorubicin%E2%80%93DNA_complex_1D12.png" class="internal" title="Enlarge"></a></div>
Diagram of two doxorubicin molecules intercalating DNA, from <span class="plainlinks"><a href="/wiki/Protein_Data_Bank" title="Protein Data Bank">PDB</a>: <a rel="nofollow" class="external text" href="http://www.rcsb.org/pdb/explore/explore.do?structureId=1D12">1D12</a></span>&#160;.<sup id="cite_ref-frederick_33-0" class="reference"><a href="#cite_note-frederick-33"><span>[</span>33<span>]</span></a></sup></div>
</div>
</div>
<p>Doxorubicin interacts with DNA by <a href="/wiki/Intercalation_(chemistry)" title="Intercalation (chemistry)">intercalation</a> and inhibition of macromolecular <a href="/wiki/Biosynthesis" title="Biosynthesis">biosynthesis</a>.<sup id="cite_ref-mech_3-1" class="reference"><a href="#cite_note-mech-3"><span>[</span>3<span>]</span></a></sup><sup id="cite_ref-fornari_34-0" class="reference"><a href="#cite_note-fornari-34"><span>[</span>34<span>]</span></a></sup><sup id="cite_ref-momparler_35-0" class="reference"><a href="#cite_note-momparler-35"><span>[</span>35<span>]</span></a></sup> This inhibits the progression of the enzyme <a href="/wiki/Topoisomerase_II" title="Topoisomerase II" class="mw-redirect">topoisomerase II</a>, which relaxes supercoils in DNA for <a href="/wiki/Transcription_(genetics)" title="Transcription (genetics)">transcription</a>.<sup id="cite_ref-36" class="reference"><a href="#cite_note-36"><span>[</span>36<span>]</span></a></sup> Doxorubicin stabilizes the topoisomerase II complex after it has broken the DNA chain for replication, preventing the DNA double helix from being resealed and thereby stopping the process of <a href="/wiki/DNA_replication" title="DNA replication">replication</a>.<sup id="cite_ref-mech_3-2" class="reference"><a href="#cite_note-mech-3"><span>[</span>3<span>]</span></a></sup> It may also increase free radical production, hence contributing to its cytotoxicity.<sup id="cite_ref-AMH_4-3" class="reference"><a href="#cite_note-AMH-4"><span>[</span>4<span>]</span></a></sup></p>
<p>The planar aromatic chromophore portion of the molecule intercalates between two base pairs of the DNA, while the six-membered daunosamine sugar sits in the minor groove and interacts with flanking base pairs immediately adjacent to the intercalation site, as evidenced by several crystal structures.<sup id="cite_ref-frederick_33-1" class="reference"><a href="#cite_note-frederick-33"><span>[</span>33<span>]</span></a></sup><sup id="cite_ref-pigram_37-0" class="reference"><a href="#cite_note-pigram-37"><span>[</span>37<span>]</span></a></sup></p>
<p>By <a href="/wiki/Intercalation_(chemistry)" title="Intercalation (chemistry)">intercalation</a>, doxorubicin can also induce <a href="/wiki/Histone" title="Histone">histone</a> eviction from <a href="/wiki/Chromatin" title="Chromatin">chromatin</a>. As a result, <a href="/wiki/DNA_repair" title="DNA repair">DNA damage response</a>, <a href="/wiki/Epigenome" title="Epigenome">epigenome</a> and <a href="/wiki/Transcriptome" title="Transcriptome">transcriptome</a> are deregulated in doxorubicin-exposed cells.<sup id="cite_ref-Pang_38-0" class="reference"><a href="#cite_note-Pang-38"><span>[</span>38<span>]</span></a></sup></p>
<h2><span class="mw-headline" id="History">History</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Doxorubicin&amp;action=edit&amp;section=10" title="Edit section: History">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<div class="hatnote">See also: <a href="/wiki/History_of_cancer_chemotherapy" title="History of cancer chemotherapy">History of cancer chemotherapy</a></div>
<p>In the 1950s, an Italian research company, <a href="/w/index.php?title=Farmitalia&amp;action=edit&amp;redlink=1" class="new" title="Farmitalia (page does not exist)">Farmitalia</a> Research Laboratories, began an organized effort to find anticancer compounds from soil-based microbes. A soil sample was isolated from the area surrounding the <a href="/wiki/Castel_del_Monte,_Apulia" title="Castel del Monte, Apulia">Castel del Monte</a>, a 13th-century castle. A new strain of <i><a href="/wiki/Streptomyces_peucetius" title="Streptomyces peucetius">Streptomyces peucetius</a></i>, which produced a red pigment, was isolated, and an antibiotic from this bacterium was effective against tumors in mice. Since a group of French researchers discovered the same compound at about the same time, the two teams named the compound <a href="/wiki/Daunorubicin" title="Daunorubicin">daunorubicin</a>, combining the name <i><a href="/wiki/Dauni" title="Dauni" class="mw-redirect">Dauni</a></i>, a pre-Roman tribe that occupied the area of Italy where the compound was isolated, with the French word for <a href="/wiki/Ruby" title="Ruby">ruby</a>, <i>rubis</i>, describing the color.<sup id="cite_ref-weiss_39-0" class="reference"><a href="#cite_note-weiss-39"><span>[</span>39<span>]</span></a></sup> Clinical trials began in the 1960s, and the drug was successful in treating acute leukemia and lymphoma. However, by 1967, it was recognized that daunorubicin could produce fatal cardiac toxicity.<sup id="cite_ref-TanC_40-0" class="reference"><a href="#cite_note-TanC-40"><span>[</span>40<span>]</span></a></sup></p>
<p>Researchers at Farmitalia soon discovered that changes in biological activity could be made by minor changes in the structure of the compound. A strain of <i>Streptomyces</i> was mutated using <i>N</i>-nitroso-<i>N</i>-methyl urethane, and this new strain produced a different, red-colored antibiotic. They named this new compound Adriamycin, after the <a href="/wiki/Adriatic_Sea" title="Adriatic Sea">Adriatic Sea</a>, and the name was later changed to doxorubicin to conform to the established naming convention.<sup id="cite_ref-pmid5365804_27-1" class="reference"><a href="#cite_note-pmid5365804-27"><span>[</span>27<span>]</span></a></sup> Doxorubicin showed better activity than daunorubicin against mouse tumors, and especially solid tumors. It also showed a higher <a href="/wiki/Therapeutic_index" title="Therapeutic index">therapeutic index</a>, yet the <a href="/wiki/Cardiotoxicity" title="Cardiotoxicity">cardiotoxicity</a> remained.<sup id="cite_ref-DiMarcoA_41-0" class="reference"><a href="#cite_note-DiMarcoA-41"><span>[</span>41<span>]</span></a></sup></p>
<p>Doxorubicin and daunorubicin together can be thought of as prototype compounds for the anthracyclines. Subsequent research has led to many other anthracycline antibiotics, or analogs, and there are now over 2,000 known analogs of doxorubicin. By 1991, 553 of them had been evaluated in the screening program at the <a href="/wiki/National_Cancer_Institute" title="National Cancer Institute">National Cancer Institute</a> (NCI).<sup id="cite_ref-weiss_39-1" class="reference"><a href="#cite_note-weiss-39"><span>[</span>39<span>]</span></a></sup></p>
<h2><span class="mw-headline" id="See_also">See also</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Doxorubicin&amp;action=edit&amp;section=11" title="Edit section: See also">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<ul>
<li><a href="/wiki/Chemotherapy_regimen" title="Chemotherapy regimen">Chemotherapy regimen</a>
<ul>
<li><a href="/wiki/ABVD" title="ABVD">ABVD</a></li>
<li><a href="/wiki/BEACOPP" title="BEACOPP">BEACOPP</a></li>
<li><a href="/wiki/CHOP" title="CHOP">CHOP</a></li>
</ul>
</li>
</ul>
<h2><span class="mw-headline" id="References">References</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Doxorubicin&amp;action=edit&amp;section=12" title="Edit section: References">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<div class="reflist references-column-width" style="-moz-column-width: 30em; -webkit-column-width: 30em; column-width: 30em; list-style-type: decimal;">
<ol class="references">
<li id="cite_note-MSR-1"><span class="mw-cite-backlink">^ <a href="#cite_ref-MSR_1-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-MSR_1-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-MSR_1-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><span class="citation web"><a rel="nofollow" class="external text" href="http://reference.medscape.com/drug/doxorubicin-342120#showall">"(doxorubicin) dosing, indications, interactions, adverse effects, and more"</a>. <i>Medscape Reference</i>. WebMD<span class="reference-accessdate">. Retrieved <span class="nowrap">15 April</span> 2014</span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADoxorubicin&amp;rft.atitle=%28doxorubicin%29+dosing%2C+indications%2C+interactions%2C+adverse+effects%2C+and+more&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Freference.medscape.com%2Fdrug%2Fdoxorubicin-342120%23showall&amp;rft.jtitle=Medscape+Reference&amp;rft.pub=WebMD&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-MD-2"><span class="mw-cite-backlink">^ <a href="#cite_ref-MD_2-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-MD_2-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-MD_2-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-MD_2-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-MD_2-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-MD_2-5"><sup><i><b>f</b></i></sup></a> <a href="#cite_ref-MD_2-6"><sup><i><b>g</b></i></sup></a> <a href="#cite_ref-MD_2-7"><sup><i><b>h</b></i></sup></a> <a href="#cite_ref-MD_2-8"><sup><i><b>i</b></i></sup></a></span> <span class="reference-text"><span class="citation web">Brayfield, A, ed. (19 December 2013). <a rel="nofollow" class="external text" href="http://www.medicinescomplete.com/mc/martindale/current/ms-21514-e.htm">"Doxorubicin"</a>. <i>Martindale: The Complete Drug Reference</i>. Pharmaceutical Press<span class="reference-accessdate">. Retrieved <span class="nowrap">15 April</span> 2014</span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADoxorubicin&amp;rft.atitle=Doxorubicin&amp;rft.date=19+December+2013&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fwww.medicinescomplete.com%2Fmc%2Fmartindale%2Fcurrent%2Fms-21514-e.htm&amp;rft.jtitle=Martindale%3A+The+Complete+Drug+Reference&amp;rft.pub=Pharmaceutical+Press&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-mech-3"><span class="mw-cite-backlink">^ <a href="#cite_ref-mech_3-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-mech_3-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-mech_3-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Tacar, O; Sriamornsak, P; Dass, CR (February 2013). "Doxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systems.". <i>The Journal of Pharmacy and Pharmacology</i> <b>65</b> (2): 157–70. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1111%2Fj.2042-7158.2012.01567.x">10.1111/j.2042-7158.2012.01567.x</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/23278683">23278683</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADoxorubicin&amp;rft.atitle=Doxorubicin%3A+an+update+on+anticancer+molecular+action%2C+toxicity+and+novel+drug+delivery+systems.&amp;rft.au=Dass%2C+CR&amp;rft.aufirst=O&amp;rft.aulast=Tacar&amp;rft.au=Sriamornsak%2C+P&amp;rft.au=Tacar%2C+O&amp;rft.date=February+2013&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1111%2Fj.2042-7158.2012.01567.x&amp;rft_id=info%3Apmid%2F23278683&amp;rft.issue=2&amp;rft.jtitle=The+Journal+of+Pharmacy+and+Pharmacology&amp;rft.pages=157-70&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=65" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-AMH-4"><span class="mw-cite-backlink">^ <a href="#cite_ref-AMH_4-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-AMH_4-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-AMH_4-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-AMH_4-3"><sup><i><b>d</b></i></sup></a></span> <span class="reference-text"><span class="citation book">Rossi, S, ed. (2013). <i>Australian Medicines Handbook</i> (2013 ed.). Adelaide: The Australian Medicines Handbook Unit Trust. <a href="/wiki/International_Standard_Book_Number" title="International Standard Book Number">ISBN</a>&#160;<a href="/wiki/Special:BookSources/978-0-9805790-9-3" title="Special:BookSources/978-0-9805790-9-3">978-0-9805790-9-3</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADoxorubicin&amp;rft.btitle=Australian+Medicines+Handbook&amp;rft.date=2013&amp;rft.edition=2013&amp;rft.genre=book&amp;rft.isbn=978-0-9805790-9-3&amp;rft.place=Adelaide&amp;rft.pub=The+Australian+Medicines+Handbook+Unit+Trust&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Doxil_info-5"><span class="mw-cite-backlink">^ <a href="#cite_ref-Doxil_info_5-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Doxil_info_5-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text">"<a rel="nofollow" class="external text" href="http://www.orthobiotech.com/common/prescribing_information/DOXIL/PDF/DOXIL_PI_Booklet.pdf">DOXIL Product Information</a>." <i><a rel="nofollow" class="external text" href="http://www.orthobiotech.com/">Ortho Biotech Products, L.P.</a></i> Retrieved on April 19, 2007. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20070921075517/http://www.orthobiotech.com/common/prescribing_information/DOXIL/PDF/DOXIL_PI_Booklet.pdf">Archived</a> September 21, 2007 at the <a href="/wiki/Wayback_Machine" title="Wayback Machine">Wayback Machine</a></span></li>
<li id="cite_note-6"><span class="mw-cite-backlink"><b><a href="#cite_ref-6">^</a></b></span> <span class="reference-text"><span class="citation web"><a rel="nofollow" class="external text" href="http://www.fda.gov/Drugs/DrugSafety/DrugShortages/ucm314739.htm#doxorubicin">"Drug Shortages, doxorubicin"</a>. US Food and Drug Administration<span class="reference-accessdate">. Retrieved <span class="nowrap">2014-02-22</span></span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADoxorubicin&amp;rft.btitle=Drug+Shortages%2C+doxorubicin&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Fwww.fda.gov%2FDrugs%2FDrugSafety%2FDrugShortages%2Fucm314739.htm%23doxorubicin&amp;rft.pub=US+Food+and+Drug+Administration&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-7"><span class="mw-cite-backlink"><b><a href="#cite_ref-7">^</a></b></span> <span class="reference-text"><span class="citation web">Peter Loftus (2011-07-21). <a rel="nofollow" class="external text" href="http://online.wsj.com/article/SB10001424053111903554904576460290484704816.html">"J&amp;J is Short of Cancer Drug Doxil"</a>. Wall Street Journal.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADoxorubicin&amp;rft.aulast=Peter+Loftus&amp;rft.au=Peter+Loftus&amp;rft.btitle=J%26J+is+Short+of+Cancer+Drug+Doxil&amp;rft.date=2011-07-21&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Fonline.wsj.com%2Farticle%2FSB10001424053111903554904576460290484704816.html&amp;rft.pub=Wall+Street+Journal&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-8"><span class="mw-cite-backlink"><b><a href="#cite_ref-8">^</a></b></span> <span class="reference-text"><span class="citation web"><a rel="nofollow" class="external text" href="http://www.fda.gov/Drugs/DrugSafety/ucm281782.htm">"Ben Venue Laboratories – Voluntary Shutdown"</a>. US Food and Drug Administration. 2011-11-30<span class="reference-accessdate">. Retrieved <span class="nowrap">2014-02-22</span></span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADoxorubicin&amp;rft.btitle=Ben+Venue+Laboratories+%E2%80%93+Voluntary+Shutdown&amp;rft.date=2011-11-30&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Fwww.fda.gov%2FDrugs%2FDrugSafety%2Fucm281782.htm&amp;rft.pub=US+Food+and+Drug+Administration&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-9"><span class="mw-cite-backlink"><b><a href="#cite_ref-9">^</a></b></span> <span class="reference-text"><span class="citation web">Harris, Gardiner (2012-02-21). <a rel="nofollow" class="external text" href="http://www.nytimes.com/2012/02/22/health/policy/fda-approves-imports-amid-shortage-of-2-cancer-drugs.html?_r=0">"Shipments From Abroad to Help Ease Shortage of Two Cancer Drugs"</a>. New York Times<span class="reference-accessdate">. Retrieved <span class="nowrap">2014-02-22</span></span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADoxorubicin&amp;rft.aufirst=Gardiner&amp;rft.au=Harris%2C+Gardiner&amp;rft.aulast=Harris&amp;rft.btitle=Shipments+From+Abroad+to+Help+Ease+Shortage+of+Two+Cancer+Drugs&amp;rft.date=2012-02-21&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Fwww.nytimes.com%2F2012%2F02%2F22%2Fhealth%2Fpolicy%2Ffda-approves-imports-amid-shortage-of-2-cancer-drugs.html%3F_r%3D0&amp;rft.pub=New+York+Times&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-10"><span class="mw-cite-backlink"><b><a href="#cite_ref-10">^</a></b></span> <span class="reference-text"><span class="citation web">Yukhananov, Anna (2012-02-21). <a rel="nofollow" class="external text" href="http://www.reuters.com/article/2013/02/04/us-cancer-drug-approval-idUSBRE9130U320130204">"FDA acts to stem shortages of two cancer drugs"</a>. Reuters<span class="reference-accessdate">. Retrieved <span class="nowrap">2014-02-22</span></span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADoxorubicin&amp;rft.aufirst=Anna&amp;rft.aulast=Yukhananov&amp;rft.au=Yukhananov%2C+Anna&amp;rft.btitle=FDA+acts+to+stem+shortages+of+two+cancer+drugs&amp;rft.date=2012-02-21&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Fwww.reuters.com%2Farticle%2F2013%2F02%2F04%2Fus-cancer-drug-approval-idUSBRE9130U320130204&amp;rft.pub=Reuters&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-11"><span class="mw-cite-backlink"><b><a href="#cite_ref-11">^</a></b></span> <span class="reference-text"><span class="citation web"><a rel="nofollow" class="external text" href="http://www.fda.gov/newsevents/newsroom/pressannouncements/ucm337872.htm">"FDA NEWS RELEASE"</a>. US Food and Drug Administration. 2013-02-04<span class="reference-accessdate">. Retrieved <span class="nowrap">2014-02-22</span></span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADoxorubicin&amp;rft.btitle=FDA+NEWS+RELEASE&amp;rft.date=2013-02-04&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Fwww.fda.gov%2Fnewsevents%2Fnewsroom%2Fpressannouncements%2Fucm337872.htm&amp;rft.pub=US+Food+and+Drug+Administration&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-12"><span class="mw-cite-backlink"><b><a href="#cite_ref-12">^</a></b></span> <span class="reference-text"><span class="citation journal">Wendel H, De Stanchina E, Fridman J, Malina A, Ray S, Kogan S, <a href="/wiki/Carlos_Cordon-Cardo" title="Carlos Cordon-Cardo">Cordon-Cardo C</a>, Pelletier J, Lowe S (2004). "Survival signalling by Akt and eIF4E in oncogenesis and cancer therapy". <i><a href="/wiki/Nature_(journal)" title="Nature (journal)">Nature</a></i> <b>428</b> (6980): 332–7. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1038%2Fnature02369">10.1038/nature02369</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/15029198">15029198</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADoxorubicin&amp;rft.atitle=Survival+signalling+by+Akt+and+eIF4E+in+oncogenesis+and+cancer+therapy&amp;rft.aulast=Wendel+H%2C+De+Stanchina+E%2C+Fridman+J%2C+Malina+A%2C+Ray+S%2C+Kogan+S%2C+Cordon-Cardo+C%2C+Pelletier+J%2C+Lowe+S&amp;rft.au=Wendel+H%2C+De+Stanchina+E%2C+Fridman+J%2C+Malina+A%2C+Ray+S%2C+Kogan+S%2C+Cordon-Cardo+C%2C+Pelletier+J%2C+Lowe+S&amp;rft.date=2004&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1038%2Fnature02369&amp;rft_id=info%3Apmid%2F15029198&amp;rft.issue=6980&amp;rft.jtitle=Nature&amp;rft.pages=332-7&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=428" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-13"><span class="mw-cite-backlink"><b><a href="#cite_ref-13">^</a></b></span> <span class="reference-text"><span class="citation journal">Johansson S, Goldenberg D, Griffiths G, Wahren B, Hinkula J (2006). "Elimination of HIV-1 infection by treatment with a doxorubicin-conjugated anti-envelope antibody". <i>AIDS</i> <b>20</b> (15): 1911–1915. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1097%2F01.aids.0000247111.58961.60">10.1097/01.aids.0000247111.58961.60</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/16988511">16988511</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADoxorubicin&amp;rft.atitle=Elimination+of+HIV-1+infection+by+treatment+with+a+doxorubicin-conjugated+anti-envelope+antibody&amp;rft.au=Johansson+S%2C+Goldenberg+D%2C+Griffiths+G%2C+Wahren+B%2C+Hinkula+J&amp;rft.aulast=Johansson+S%2C+Goldenberg+D%2C+Griffiths+G%2C+Wahren+B%2C+Hinkula+J&amp;rft.date=2006&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1097%2F01.aids.0000247111.58961.60&amp;rft_id=info%3Apmid%2F16988511&amp;rft.issue=15&amp;rft.jtitle=AIDS&amp;rft.pages=1911-1915&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=20" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Macmillan-14"><span class="mw-cite-backlink">^ <a href="#cite_ref-Macmillan_14-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Macmillan_14-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><span class="citation web"><a rel="nofollow" class="external text" href="http://www.macmillan.org.uk/Cancerinformation/Cancertreatment/Treatmenttypes/Chemotherapy/Individualdrugs/Liposomaldoxorubicin.aspx">"Liposomal doxorubicin (Caelyx, Myocet)"</a>. Macmillan Cancer Support. April 1, 2009<span class="reference-accessdate">. Retrieved <span class="nowrap">2009-11-27</span></span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADoxorubicin&amp;rft.btitle=Liposomal+doxorubicin+%28Caelyx%2C+Myocet%29&amp;rft.date=April+1%2C+2009&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Fwww.macmillan.org.uk%2FCancerinformation%2FCancertreatment%2FTreatmenttypes%2FChemotherapy%2FIndividualdrugs%2FLiposomaldoxorubicin.aspx&amp;rft.pub=Macmillan+Cancer+Support&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-15"><span class="mw-cite-backlink"><b><a href="#cite_ref-15">^</a></b></span> <span class="reference-text"><span class="citation web"><a rel="nofollow" class="external text" href="http://www.chemocare.com/bio/doxorubicin_liposomal.asp">"Doxorubicin liposomal"</a>. <i>Chemocare</i>. <a href="/wiki/Cleveland_Clinic" title="Cleveland Clinic">Cleveland Clinic</a><span class="reference-accessdate">. Retrieved <span class="nowrap">2009-11-27</span></span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADoxorubicin&amp;rft.atitle=Doxorubicin+liposomal&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fwww.chemocare.com%2Fbio%2Fdoxorubicin_liposomal.asp&amp;rft.jtitle=Chemocare&amp;rft.pub=Cleveland+Clinic&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-16"><span class="mw-cite-backlink"><b><a href="#cite_ref-16">^</a></b></span> <span class="reference-text"><span class="citation journal">Krysko DV, Kaczmarek A, Krysko O, Heyndrickx L, Woznicki J, Bogaert P, Cauwels A, Takahashi N, Magez S, Bachert C, Vandenabeele P J (2011). "TLR-2 and TLR-9 are sensors of apoptosis in a mouse model of doxorubicin-induced acute inflammation.". <i>Cell Death Differ.</i> <b>18</b> (8): 1316–25. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1038%2Fcdd.2011.4">10.1038/cdd.2011.4</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/21311566">21311566</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADoxorubicin&amp;rft.atitle=TLR-2+and+TLR-9+are+sensors+of+apoptosis+in+a+mouse+model+of+doxorubicin-induced+acute+inflammation.&amp;rft.au=Krysko+DV%2C+Kaczmarek+A%2C+Krysko+O%2C+Heyndrickx+L%2C+Woznicki+J%2C+Bogaert+P%2C+Cauwels+A%2C+Takahashi+N%2C+Magez+S%2C+Bachert+C%2C+Vandenabeele+P+J&amp;rft.aulast=Krysko+DV%2C+Kaczmarek+A%2C+Krysko+O%2C+Heyndrickx+L%2C+Woznicki+J%2C+Bogaert+P%2C+Cauwels+A%2C+Takahashi+N%2C+Magez+S%2C+Bachert+C%2C+Vandenabeele+P+J&amp;rft.date=2011&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1038%2Fcdd.2011.4&amp;rft_id=info%3Apmid%2F21311566&amp;rft.issue=8&amp;rft.jtitle=Cell+Death+Differ.&amp;rft.pages=1316-25&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=18" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-friedman-17"><span class="mw-cite-backlink"><b><a href="#cite_ref-friedman_17-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Friedman R, Caflisch A (2009). <a rel="nofollow" class="external text" href="http://www3.interscience.wiley.com/journal/122407624/abstract?CRETRY=1&amp;SRETRY=0">"Discovery of Plasmepsin Inhibitors by Fragment-Based Docking and Consensus Scoring"</a>. <i>ChemMedChem</i> <b>4</b> (8): 1317–26. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1002%2Fcmdc.200900078">10.1002/cmdc.200900078</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/19472268">19472268</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADoxorubicin&amp;rft.atitle=Discovery+of+Plasmepsin+Inhibitors+by+Fragment-Based+Docking+and+Consensus+Scoring&amp;rft.au=Friedman+R%2C+Caflisch+A&amp;rft.aulast=Friedman+R%2C+Caflisch+A&amp;rft.date=2009&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fwww3.interscience.wiley.com%2Fjournal%2F122407624%2Fabstract%3FCRETRY%3D1%26SRETRY%3D0&amp;rft_id=info%3Adoi%2F10.1002%2Fcmdc.200900078&amp;rft_id=info%3Apmid%2F19472268&amp;rft.issue=8&amp;rft.jtitle=ChemMedChem&amp;rft.pages=1317-26&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=4" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Gamo-18"><span class="mw-cite-backlink"><b><a href="#cite_ref-Gamo_18-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Gamo F-J et al. (2010). <a rel="nofollow" class="external text" href="http://www.nature.com/nature/journal/v465/n7296/full/nature09107.html">"Thousands of chemical starting points for antimalarial lead identification"</a>. <i>Nature</i> <b>465</b> (7296): 305–310. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1038%2Fnature09107">10.1038/nature09107</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/20485427">20485427</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADoxorubicin&amp;rft.atitle=Thousands+of+chemical+starting+points+for+antimalarial+lead+identification&amp;rft.au=Gamo+F-J&amp;rft.aulast=Gamo+F-J&amp;rft.date=2010&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fwww.nature.com%2Fnature%2Fjournal%2Fv465%2Fn7296%2Ffull%2Fnature09107.html&amp;rft_id=info%3Adoi%2F10.1038%2Fnature09107&amp;rft_id=info%3Apmid%2F20485427&amp;rft.issue=7296&amp;rft.jtitle=Nature&amp;rft.pages=305-310&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=465" class="Z3988"><span style="display:none;">&#160;</span></span> <span class="citation-comment" style="display:none; color:#33aa33">CS1 maint: Explicit use of et al. (<a href="/wiki/Category:CS1_maint:_Explicit_use_of_et_al." title="Category:CS1 maint: Explicit use of et al.">link</a>)</span></span></li>
<li id="cite_note-Chaterjee-19"><span class="mw-cite-backlink">^ <a href="#cite_ref-Chaterjee_19-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Chaterjee_19-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Chaterjee, Kanu; Jianqing Zhang; Norman Honbo; Joel S. Karliner (January 2010). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2848530">"Doxorubicin Cardiomyopathy"</a>. <i>Cardiology</i> <b>115</b> (2): 155–162. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1159%2F000265166">10.1159/000265166</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2848530">2848530</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/20016174">20016174</a><span class="reference-accessdate">. Retrieved <span class="nowrap">22 January</span> 2014</span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADoxorubicin&amp;rft.atitle=Doxorubicin+Cardiomyopathy&amp;rft.au=Chaterjee%2C+Kanu&amp;rft.aufirst=Kanu&amp;rft.au=Jianqing+Zhang&amp;rft.au=Joel+S.+Karliner&amp;rft.aulast=Chaterjee&amp;rft.au=Norman+Honbo&amp;rft.date=January+2010&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2848530&amp;rft_id=info%3Adoi%2F10.1159%2F000265166&amp;rft_id=info%3Apmc%2F2848530&amp;rft_id=info%3Apmid%2F20016174&amp;rft.issue=2&amp;rft.jtitle=Cardiology&amp;rft.pages=155-162&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=115" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-20"><span class="mw-cite-backlink"><b><a href="#cite_ref-20">^</a></b></span> <span class="reference-text"><span class="citation journal">Kaczmarek A, Brinkman BM, Heyndrickx L, Vandenabeele P, Krysko DV J (2012). "Severity of doxorubicin-induced small intestinal mucositis is regulated by the TLR-2 and TLR-9 pathways.". <i>J Pathol.</i> <b>226</b> (4): 598–608. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1002%2Fpath.3009">10.1002/path.3009</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/21960132">21960132</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADoxorubicin&amp;rft.atitle=Severity+of+doxorubicin-induced+small+intestinal+mucositis+is+regulated+by+the+TLR-2+and+TLR-9+pathways.&amp;rft.au=Kaczmarek+A%2C+Brinkman+BM%2C+Heyndrickx+L%2C+Vandenabeele+P%2C+Krysko+DV+J&amp;rft.aulast=Kaczmarek+A%2C+Brinkman+BM%2C+Heyndrickx+L%2C+Vandenabeele+P%2C+Krysko+DV+J&amp;rft.date=2012&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1002%2Fpath.3009&amp;rft_id=info%3Apmid%2F21960132&amp;rft.issue=4&amp;rft.jtitle=J+Pathol.&amp;rft.pages=598-608&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=226" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-BlochCancerFaq-21"><span class="mw-cite-backlink"><b><a href="#cite_ref-BlochCancerFaq_21-0">^</a></b></span> <span class="reference-text"><span class="citation web">Bloch, Richard; Bloch, Annette. <a rel="nofollow" class="external text" href="http://web.archive.org/web/20070626082335/http://www.blochcancer.org/fighting/chap13.html">"25 Most Asked Questions"</a>. <i>Fighting Cancer</i>. R. A. Bloch Cancer Foundation. Archived from <a rel="nofollow" class="external text" href="http://www.blochcancer.org/fighting/chap13.html">the original</a> on June 26, 2007<span class="reference-accessdate">. Retrieved <span class="nowrap">2007-06-28</span></span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADoxorubicin&amp;rft.atitle=25+Most+Asked+Questions&amp;rft.au=Bloch%2C+Annette&amp;rft.au=Bloch%2C+Richard&amp;rft.aufirst=Richard&amp;rft.aulast=Bloch&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fwww.blochcancer.org%2Ffighting%2Fchap13.html&amp;rft.jtitle=Fighting+Cancer&amp;rft.pub=R.+A.+Bloch+Cancer+Foundation&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-22"><span class="mw-cite-backlink"><b><a href="#cite_ref-22">^</a></b></span> <span class="reference-text"><span class="citation book"><a href="/wiki/Jerome_Groopman" title="Jerome Groopman">Groopman, Jerome E.</a> (2007). <i><a href="/wiki/How_Doctors_Think" title="How Doctors Think">How Doctors Think</a></i>. Boston: Houghton Mifflin. p.&#160;49. <a href="/wiki/International_Standard_Book_Number" title="International Standard Book Number">ISBN</a>&#160;<a href="/wiki/Special:BookSources/0-618-61003-0" title="Special:BookSources/0-618-61003-0">0-618-61003-0</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADoxorubicin&amp;rft.au=Groopman%2C+Jerome+E.&amp;rft.aulast=Groopman%2C+Jerome+E.&amp;rft.btitle=How+Doctors+Think&amp;rft.date=2007&amp;rft.genre=book&amp;rft.isbn=0-618-61003-0&amp;rft.pages=49&amp;rft.place=Boston&amp;rft.pub=Houghton+Mifflin&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-23"><span class="mw-cite-backlink"><b><a href="#cite_ref-23">^</a></b></span> <span class="reference-text"><span class="citation journal">Yeo W, Lam KC, Zee B et al. (November 2004). "Hepatitis B reactivation in patients with hepatocellular carcinoma undergoing systemic chemotherapy". <i><a href="/wiki/Annals_of_Oncology" title="Annals of Oncology">Ann Oncol</a></i> <b>15</b> (11): 1661–6. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1093%2Fannonc%2Fmdh430">10.1093/annonc/mdh430</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/15520068">15520068</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADoxorubicin&amp;rft.atitle=Hepatitis+B+reactivation+in+patients+with+hepatocellular+carcinoma+undergoing+systemic+chemotherapy&amp;rft.aulast=Yeo+W%2C+Lam+KC%2C+Zee+B&amp;rft.au=Yeo+W%2C+Lam+KC%2C+Zee+B&amp;rft.date=November+2004&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1093%2Fannonc%2Fmdh430&amp;rft_id=info%3Apmid%2F15520068&amp;rft.issue=11&amp;rft.jtitle=Ann+Oncol&amp;rft.pages=1661-6&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=15" class="Z3988"><span style="display:none;">&#160;</span></span> <span class="citation-comment" style="display:none; color:#33aa33">CS1 maint: Explicit use of et al. (<a href="/wiki/Category:CS1_maint:_Explicit_use_of_et_al." title="Category:CS1 maint: Explicit use of et al.">link</a>)</span></span></li>
<li id="cite_note-24"><span class="mw-cite-backlink"><b><a href="#cite_ref-24">^</a></b></span> <span class="reference-text"><span class="citation journal">Dillon R, Hirschfield GM, Allison ME, Rege KP (2008). "Fatal reactivation of hepatitis B after chemotherapy for lymphoma". <i><a href="/wiki/BMJ" title="BMJ">BMJ</a></i> <b>337</b>: a423. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1136%2Fbmj.39490.680498.BE">10.1136/bmj.39490.680498.BE</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/18595895">18595895</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADoxorubicin&amp;rft.atitle=Fatal+reactivation+of+hepatitis+B+after+chemotherapy+for+lymphoma&amp;rft.au=Dillon+R%2C+Hirschfield+GM%2C+Allison+ME%2C+Rege+KP&amp;rft.aulast=Dillon+R%2C+Hirschfield+GM%2C+Allison+ME%2C+Rege+KP&amp;rft.date=2008&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1136%2Fbmj.39490.680498.BE&amp;rft_id=info%3Apmid%2F18595895&amp;rft.jtitle=BMJ&amp;rft.pages=a423&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=337" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-25"><span class="mw-cite-backlink"><b><a href="#cite_ref-25">^</a></b></span> <span class="reference-text"><a rel="nofollow" class="external free" href="http://www.nejm.org/image-challenge?ci=09012011&amp;query=TOC">http://www.nejm.org/image-challenge?ci=09012011&amp;query=TOC</a></span></li>
<li id="cite_note-pmid9864344-26"><span class="mw-cite-backlink">^ <a href="#cite_ref-pmid9864344_26-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid9864344_26-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Lomovskaya N, Otten SL, Doi-Katayama Y et al. (1999). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC103563">"Doxorubicin overproduction in <i>Streptomyces peucetius</i>: cloning and characterization of the dnrU ketoreductase and dnrV genes and the doxA cytochrome P-450 hydroxylase gene"</a>. <i>J. Bacteriol.</i> <b>181</b> (1): 305–18. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC103563">103563</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/9864344">9864344</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADoxorubicin&amp;rft.atitle=Doxorubicin+overproduction+in+Streptomyces+peucetius%3A+cloning+and+characterization+of+the+dnrU+ketoreductase+and+dnrV+genes+and+the+doxA+cytochrome+P-450+hydroxylase+gene&amp;rft.aulast=Lomovskaya+N%2C+Otten+SL%2C+Doi-Katayama+Y&amp;rft.au=Lomovskaya+N%2C+Otten+SL%2C+Doi-Katayama+Y&amp;rft.date=1999&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC103563&amp;rft_id=info%3Apmc%2F103563&amp;rft_id=info%3Apmid%2F9864344&amp;rft.issue=1&amp;rft.jtitle=J.+Bacteriol.&amp;rft.pages=305-18&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=181" class="Z3988"><span style="display:none;">&#160;</span></span> <span class="citation-comment" style="display:none; color:#33aa33">CS1 maint: Explicit use of et al. (<a href="/wiki/Category:CS1_maint:_Explicit_use_of_et_al." title="Category:CS1 maint: Explicit use of et al.">link</a>)</span></span></li>
<li id="cite_note-pmid5365804-27"><span class="mw-cite-backlink">^ <a href="#cite_ref-pmid5365804_27-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid5365804_27-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Arcamone F, Cassinelli G, Fantini G et al. (1969). "Adriamycin, 14-hydroxydaunomycin, a new antitumor antibiotic from <i>S. peucetius</i> var. <i>caesius</i>". <i>Biotechnol Bioeng</i> <b>11</b> (6): 1101–10. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1002%2Fbit.260110607">10.1002/bit.260110607</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/5365804">5365804</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADoxorubicin&amp;rft.atitle=Adriamycin%2C+14-hydroxydaunomycin%2C+a+new+antitumor+antibiotic+from+S.+peucetius+var.+caesius&amp;rft.au=Arcamone+F%2C+Cassinelli+G%2C+Fantini+G&amp;rft.aulast=Arcamone+F%2C+Cassinelli+G%2C+Fantini+G&amp;rft.date=1969&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1002%2Fbit.260110607&amp;rft_id=info%3Apmid%2F5365804&amp;rft.issue=6&amp;rft.jtitle=Biotechnol+Bioeng&amp;rft.pages=1101-10&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=11" class="Z3988"><span style="display:none;">&#160;</span></span> <span class="citation-comment" style="display:none; color:#33aa33">CS1 maint: Explicit use of et al. (<a href="/wiki/Category:CS1_maint:_Explicit_use_of_et_al." title="Category:CS1 maint: Explicit use of et al.">link</a>)</span></span></li>
<li id="cite_note-pmid7828855-28"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid7828855_28-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Grimm A, Madduri K, Ali A, Hutchinson CR (1994). "Characterization of the Streptomyces peucetius ATCC 29050 genes encoding doxorubicin polyketide synthase". <i>Gene</i> <b>151</b> (1–2): 1–10. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1016%2F0378-1119%2894%2990625-4">10.1016/0378-1119(94)90625-4</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/7828855">7828855</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADoxorubicin&amp;rft.atitle=Characterization+of+the+Streptomyces+peucetius+ATCC+29050+genes+encoding+doxorubicin+polyketide+synthase&amp;rft.au=Grimm+A%2C+Madduri+K%2C+Ali+A%2C+Hutchinson+CR&amp;rft.aulast=Grimm+A%2C+Madduri+K%2C+Ali+A%2C+Hutchinson+CR&amp;rft.date=1994&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2F0378-1119%2894%2990625-4&amp;rft_id=info%3Apmid%2F7828855&amp;rft.issue=1%E2%80%932&amp;rft.jtitle=Gene&amp;rft.pages=1-10&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=151" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid8655530-29"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid8655530_29-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Dickens ML, Strohl WR (1996). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC178102">"Isolation and characterization of a gene from Streptomyces sp. strain C5 that confers the ability to convert daunomycin to doxorubicin on Streptomyces lividans TK24"</a>. <i>J. Bacteriol.</i> <b>178</b> (11): 3389–95. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC178102">178102</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/8655530">8655530</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADoxorubicin&amp;rft.atitle=Isolation+and+characterization+of+a+gene+from+Streptomyces+sp.+strain+C5+that+confers+the+ability+to+convert+daunomycin+to+doxorubicin+on+Streptomyces+lividans+TK24&amp;rft.au=Dickens+ML%2C+Strohl+WR&amp;rft.aulast=Dickens+ML%2C+Strohl+WR&amp;rft.date=1996&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC178102&amp;rft_id=info%3Apmc%2F178102&amp;rft_id=info%3Apmid%2F8655530&amp;rft.issue=11&amp;rft.jtitle=J.+Bacteriol.&amp;rft.pages=3389-95&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=178" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid9864343-30"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid9864343_30-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Walczak RJ, Dickens ML, Priestley ND, Strohl WR (1999). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC103562">"Purification, properties, and characterization of recombinant Streptomyces sp. strain C5 DoxA, a cytochrome P-450 catalyzing multiple steps in doxorubicin biosynthesis"</a>. <i>J. Bacteriol.</i> <b>181</b> (1): 298–304. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC103562">103562</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/9864343">9864343</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADoxorubicin&amp;rft.atitle=Purification%2C+properties%2C+and+characterization+of+recombinant+Streptomyces+sp.+strain+C5+DoxA%2C+a+cytochrome+P-450+catalyzing+multiple+steps+in+doxorubicin+biosynthesis&amp;rft.aulast=Walczak+RJ%2C+Dickens+ML%2C+Priestley+ND%2C+Strohl+WR&amp;rft.au=Walczak+RJ%2C+Dickens+ML%2C+Priestley+ND%2C+Strohl+WR&amp;rft.date=1999&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC103562&amp;rft_id=info%3Apmc%2F103562&amp;rft_id=info%3Apmid%2F9864343&amp;rft.issue=1&amp;rft.jtitle=J.+Bacteriol.&amp;rft.pages=298-304&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=181" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid10455495-31"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid10455495_31-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Hutchinson CR, Colombo AL (1999). "Genetic engineering of doxorubicin production in Streptomyces peucetius: a review". <i>J. Ind. Microbiol. Biotechnol.</i> <b>23</b> (1): 647–52. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1038%2Fsj.jim.2900673">10.1038/sj.jim.2900673</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/10455495">10455495</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADoxorubicin&amp;rft.atitle=Genetic+engineering+of+doxorubicin+production+in+Streptomyces+peucetius%3A+a+review&amp;rft.au=Hutchinson+CR%2C+Colombo+AL&amp;rft.aulast=Hutchinson+CR%2C+Colombo+AL&amp;rft.date=1999&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1038%2Fsj.jim.2900673&amp;rft_id=info%3Apmid%2F10455495&amp;rft.issue=1&amp;rft.jtitle=J.+Ind.+Microbiol.+Biotechnol.&amp;rft.pages=647-52&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=23" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid8022857-32"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid8022857_32-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Lown JW (1993). "Anthracycline and anthraquinone anticancer agents: current status and recent developments". <i>Pharmacol. Ther.</i> <b>60</b> (2): 185–214. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1016%2F0163-7258%2893%2990006-Y">10.1016/0163-7258(93)90006-Y</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/8022857">8022857</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADoxorubicin&amp;rft.atitle=Anthracycline+and+anthraquinone+anticancer+agents%3A+current+status+and+recent+developments&amp;rft.aulast=Lown+JW&amp;rft.au=Lown+JW&amp;rft.date=1993&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2F0163-7258%2893%2990006-Y&amp;rft_id=info%3Apmid%2F8022857&amp;rft.issue=2&amp;rft.jtitle=Pharmacol.+Ther.&amp;rft.pages=185-214&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=60" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-frederick-33"><span class="mw-cite-backlink">^ <a href="#cite_ref-frederick_33-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-frederick_33-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Frederick CA, Williams LD, Ughetto G et al. (March 1990). "Structural comparison of anticancer drug-DNA complexes: adriamycin and daunomycin". <i>Biochemistry</i> <b>29</b> (10): 2538–49. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1021%2Fbi00462a016">10.1021/bi00462a016</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/2334681">2334681</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADoxorubicin&amp;rft.atitle=Structural+comparison+of+anticancer+drug-DNA+complexes%3A+adriamycin+and+daunomycin&amp;rft.au=Frederick+CA%2C+Williams+LD%2C+Ughetto+G&amp;rft.aulast=Frederick+CA%2C+Williams+LD%2C+Ughetto+G&amp;rft.date=March+1990&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1021%2Fbi00462a016&amp;rft_id=info%3Apmid%2F2334681&amp;rft.issue=10&amp;rft.jtitle=Biochemistry&amp;rft.pages=2538-49&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=29" class="Z3988"><span style="display:none;">&#160;</span></span> <span class="citation-comment" style="display:none; color:#33aa33">CS1 maint: Explicit use of et al. (<a href="/wiki/Category:CS1_maint:_Explicit_use_of_et_al." title="Category:CS1 maint: Explicit use of et al.">link</a>)</span> Crystal structure is available for download as a <a rel="nofollow" class="external text" href="http://www.rcsb.org/pdb/explore.do?structureId=1D12">PDB</a> file.</span></li>
<li id="cite_note-fornari-34"><span class="mw-cite-backlink"><b><a href="#cite_ref-fornari_34-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Fornari FA, Randolph JK, Yalowich JC, Ritke MK, Gewirtz DA (April 1994). "Interference by doxorubicin with DNA unwinding in MCF-7 breast tumor cells". <i><a href="/wiki/Molecular_Pharmacology" title="Molecular Pharmacology">Mol Pharmacol</a></i> <b>45</b> (4): 649–56. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/8183243">8183243</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADoxorubicin&amp;rft.atitle=Interference+by+doxorubicin+with+DNA+unwinding+in+MCF-7+breast+tumor+cells&amp;rft.au=Fornari+FA%2C+Randolph+JK%2C+Yalowich+JC%2C+Ritke+MK%2C+Gewirtz+DA&amp;rft.aulast=Fornari+FA%2C+Randolph+JK%2C+Yalowich+JC%2C+Ritke+MK%2C+Gewirtz+DA&amp;rft.date=April+1994&amp;rft.genre=article&amp;rft_id=info%3Apmid%2F8183243&amp;rft.issue=4&amp;rft.jtitle=Mol+Pharmacol&amp;rft.pages=649-56&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=45" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-momparler-35"><span class="mw-cite-backlink"><b><a href="#cite_ref-momparler_35-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Momparler RL, Karon M, Siegel SE, Avila F (August 1976). <a rel="nofollow" class="external text" href="http://cancerres.aacrjournals.org/cgi/reprint/36/8/2891">"Effect of adriamycin on DNA, RNA, and protein synthesis in cell-free systems and intact cells"</a>. <i>Cancer Res</i> <b>36</b> (8): 2891–5. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/1277199">1277199</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADoxorubicin&amp;rft.atitle=Effect+of+adriamycin+on+DNA%2C+RNA%2C+and+protein+synthesis+in+cell-free+systems+and+intact+cells&amp;rft.aulast=Momparler+RL%2C+Karon+M%2C+Siegel+SE%2C+Avila+F&amp;rft.au=Momparler+RL%2C+Karon+M%2C+Siegel+SE%2C+Avila+F&amp;rft.date=August+1976&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fcancerres.aacrjournals.org%2Fcgi%2Freprint%2F36%2F8%2F2891&amp;rft_id=info%3Apmid%2F1277199&amp;rft.issue=8&amp;rft.jtitle=Cancer+Res&amp;rft.pages=2891-5&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=36" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-36"><span class="mw-cite-backlink"><b><a href="#cite_ref-36">^</a></b></span> <span class="reference-text"><span class="citation journal">Pommier, Y; Leo, E; Zhang, H; Marchand, C (May 2010). "DNA topoisomerases and their poisoning by anticancer and antibacterial drugs.". <i>Chemistry &amp; Biology</i> <b>17</b> (5): 421–33. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1016%2Fj.chembiol.2010.04.012">10.1016/j.chembiol.2010.04.012</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/20534341">20534341</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADoxorubicin&amp;rft.atitle=DNA+topoisomerases+and+their+poisoning+by+anticancer+and+antibacterial+drugs.&amp;rft.aufirst=Y&amp;rft.aulast=Pommier&amp;rft.au=Leo%2C+E&amp;rft.au=Marchand%2C+C&amp;rft.au=Pommier%2C+Y&amp;rft.au=Zhang%2C+H&amp;rft.date=May+2010&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2Fj.chembiol.2010.04.012&amp;rft_id=info%3Apmid%2F20534341&amp;rft.issue=5&amp;rft.jtitle=Chemistry+%26+Biology&amp;rft.pages=421-33&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=17" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pigram-37"><span class="mw-cite-backlink"><b><a href="#cite_ref-pigram_37-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Pigram WJ, Fuller W, Hamilton LD (January 1972). "Stereochemistry of intercalation: interaction of daunomycin with DNA". <i>Nature New Biol</i> <b>235</b> (53): 17–9. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1038%2Fnewbio235017a0">10.1038/newbio235017a0</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/4502404">4502404</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADoxorubicin&amp;rft.atitle=Stereochemistry+of+intercalation%3A+interaction+of+daunomycin+with+DNA&amp;rft.aulast=Pigram+WJ%2C+Fuller+W%2C+Hamilton+LD&amp;rft.au=Pigram+WJ%2C+Fuller+W%2C+Hamilton+LD&amp;rft.date=January+1972&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1038%2Fnewbio235017a0&amp;rft_id=info%3Apmid%2F4502404&amp;rft.issue=53&amp;rft.jtitle=Nature+New+Biol&amp;rft.pages=17-9&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=235" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Pang-38"><span class="mw-cite-backlink"><b><a href="#cite_ref-Pang_38-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Pang B, Qiao X, Janssen L, Velds A, Groothuis T, Kerkhoven R, Nieuwland M, Ovaa H, Rottenberg S, van Tellingen O, Janssen J, Huijgens P, Zwart W, Neefjes J (2013). <a rel="nofollow" class="external text" href="http://www.nature.com/ncomms/journal/v4/n5/full/ncomms2921.html">"Drug-induced histone eviction from open chromatin contributes to the chemotherapeutic effects of doxorubicin"</a>. <i>Nature Communications</i> <b>4</b> (5): 1908. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1038%2Fncomms2921">10.1038/ncomms2921</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/23715267">23715267</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADoxorubicin&amp;rft.atitle=Drug-induced+histone+eviction+from+open+chromatin+contributes+to+the+chemotherapeutic+effects+of+doxorubicin&amp;rft.aulast=Pang+B%2C+Qiao+X%2C+Janssen+L%2C+Velds+A%2C+Groothuis+T%2C+Kerkhoven+R%2C+Nieuwland+M%2C+Ovaa+H%2C+Rottenberg+S%2C+van+Tellingen+O%2C+Janssen+J%2C+Huijgens+P%2C+Zwart+W%2C+Neefjes+J&amp;rft.au=Pang+B%2C+Qiao+X%2C+Janssen+L%2C+Velds+A%2C+Groothuis+T%2C+Kerkhoven+R%2C+Nieuwland+M%2C+Ovaa+H%2C+Rottenberg+S%2C+van+Tellingen+O%2C+Janssen+J%2C+Huijgens+P%2C+Zwart+W%2C+Neefjes+J&amp;rft.date=2013&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fwww.nature.com%2Fncomms%2Fjournal%2Fv4%2Fn5%2Ffull%2Fncomms2921.html&amp;rft_id=info%3Adoi%2F10.1038%2Fncomms2921&amp;rft_id=info%3Apmid%2F23715267&amp;rft.issue=5&amp;rft.jtitle=Nature+Communications&amp;rft.pages=1908&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=4" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-weiss-39"><span class="mw-cite-backlink">^ <a href="#cite_ref-weiss_39-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-weiss_39-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Weiss RB (December 1992). "The anthracyclines: will we ever find a better doxorubicin?". <i>Seminars in Oncology</i> <b>19</b> (6): 670–86. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/1462166">1462166</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADoxorubicin&amp;rft.atitle=The+anthracyclines%3A+will+we+ever+find+a+better+doxorubicin%3F&amp;rft.aulast=Weiss+RB&amp;rft.au=Weiss+RB&amp;rft.date=December+1992&amp;rft.genre=article&amp;rft_id=info%3Apmid%2F1462166&amp;rft.issue=6&amp;rft.jtitle=Seminars+in+Oncology&amp;rft.pages=670-86&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=19" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-TanC-40"><span class="mw-cite-backlink"><b><a href="#cite_ref-TanC_40-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Tan C, Tasaka H, Yu KP, Murphy ML, Karnofsky DA (March 1967). "Daunomycin, an antitumor antibiotic, in the treatment of neoplastic disease. Clinical evaluation with special reference to childhood leukemia". <i>Cancer</i> <b>20</b> (3): 333–53. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1002%2F1097-0142%281967%2920%3A3%3C333%3A%3AAID-CNCR2820200302%3E3.0.CO%3B2-K">10.1002/1097-0142(1967)20:3&lt;333::AID-CNCR2820200302&gt;3.0.CO;2-K</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/4290058">4290058</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADoxorubicin&amp;rft.atitle=Daunomycin%2C+an+antitumor+antibiotic%2C+in+the+treatment+of+neoplastic+disease.+Clinical+evaluation+with+special+reference+to+childhood+leukemia&amp;rft.aulast=Tan+C%2C+Tasaka+H%2C+Yu+KP%2C+Murphy+ML%2C+Karnofsky+DA&amp;rft.au=Tan+C%2C+Tasaka+H%2C+Yu+KP%2C+Murphy+ML%2C+Karnofsky+DA&amp;rft.date=March+1967&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1002%2F1097-0142%281967%2920%3A3%3C333%3A%3AAID-CNCR2820200302%3E3.0.CO%3B2-K&amp;rft_id=info%3Apmid%2F4290058&amp;rft.issue=3&amp;rft.jtitle=Cancer&amp;rft.pages=333-53&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=20" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-DiMarcoA-41"><span class="mw-cite-backlink"><b><a href="#cite_ref-DiMarcoA_41-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Di Marco A, Gaetani M, Scarpinato B (February 1969). "Adriamycin (NSC-123,127): a new antibiotic with antitumor activity". <i>Cancer Chemother Rep</i> <b>53</b> (1): 33–7. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/5772652">5772652</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADoxorubicin&amp;rft.atitle=Adriamycin+%28NSC-123%2C127%29%3A+a+new+antibiotic+with+antitumor+activity&amp;rft.au=Di+Marco+A%2C+Gaetani+M%2C+Scarpinato+B&amp;rft.aulast=Di+Marco+A%2C+Gaetani+M%2C+Scarpinato+B&amp;rft.date=February+1969&amp;rft.genre=article&amp;rft_id=info%3Apmid%2F5772652&amp;rft.issue=1&amp;rft.jtitle=Cancer+Chemother+Rep&amp;rft.pages=33-7&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=53" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
</ol>
</div>
<h2><span class="mw-headline" id="External_links">External links</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Doxorubicin&amp;action=edit&amp;section=13" title="Edit section: External links">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<ul>
<li><a href="/wiki/MedlinePlus" title="MedlinePlus">MedlinePlus DrugInfo</a> <i><a rel="nofollow" class="external text" href="http://www.nlm.nih.gov/medlineplus/druginfo/medmaster/a682221.html">medmaster-a682221</a></i></li>
<li><a rel="nofollow" class="external text" href="http://www.bccancer.bc.ca/HPI/DrugDatabase/DrugIndexPro/Doxorubicin.htm">Overview</a> at <a href="/wiki/BC_Cancer_Agency" title="BC Cancer Agency">BC Cancer Agency</a></li>
<li><a rel="nofollow" class="external text" href="http://www.doxil.com">Doxil Site</a></li>
<li><a rel="nofollow" class="external text" href="http://druginfo.nlm.nih.gov/drugportal/dpdirect.jsp?name=Doxorubicin">U.S. National Library of Medicine: Drug Information Portal - Doxorubicin</a></li>
<li><a rel="nofollow" class="external text" href="http://www.yissum.co.il">Yissum</a> - the owners of the original patents for Doxil</li>
<li><a rel="nofollow" class="external autonumber" href="http://www.doxil.com/doxil-supply-shortage">[1]</a> - information regarding the Doxil shortage from Janssen</li>
<li><a rel="nofollow" class="external text" href="http://www.nanobotmodels.com/node/65">Nanodiamond doxorubicin drug delivery visualization</a></li>
</ul>
<div style="clear:both;"></div>
<table class="navbox" style="border-spacing:0">
<tr>
<td style="padding:2px">
<table class="nowraplinks collapsible collapsed navbox-inner" style="border-spacing:0;background:transparent;color:inherit">
<tr>
<th scope="col" class="navbox-title" colspan="2">
<div class="plainlinks hlist navbar mini">
<ul>
<li class="nv-view"><a href="/wiki/Template:Intracellular_chemotherapeutic_agents" title="Template:Intracellular chemotherapeutic agents"><span title="View this template" style=";;background:none transparent;border:none;">v</span></a></li>
<li class="nv-talk"><a href="/wiki/Template_talk:Intracellular_chemotherapeutic_agents" title="Template talk:Intracellular chemotherapeutic agents"><span title="Discuss this template" style=";;background:none transparent;border:none;">t</span></a></li>
<li class="nv-edit"><a class="external text" href="//en.wikipedia.org/w/index.php?title=Template:Intracellular_chemotherapeutic_agents&amp;action=edit"><span title="Edit this template" style=";;background:none transparent;border:none;">e</span></a></li>
</ul>
</div>
<div style="font-size:110%">Intracellular <a href="/wiki/Chemotherapy" title="Chemotherapy">chemotherapeutic agents</a>&#160;/ <a href="/wiki/Antineoplastic" title="Antineoplastic" class="mw-redirect">antineoplastic agents</a> (<a href="/wiki/ATC_code_L01" title="ATC code L01">L01</a>)</div>
</th>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Spindle_poison" title="Spindle poison">SPs</a>/<a href="/wiki/Mitotic_inhibitor" title="Mitotic inhibitor">MIs</a><br />
(<a href="/wiki/M_phase" title="M phase" class="mw-redirect">M phase</a>)</th>
<td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em"></div>
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th scope="row" class="navbox-group">Block <a href="/wiki/Microtubule" title="Microtubule">microtubule</a> assembly</th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><i><a href="/wiki/Catharanthus#Vinca_alkaloids" title="Catharanthus">Vinca alkaloids</a></i> (<a href="/wiki/Vinblastine" title="Vinblastine">Vinblastine</a><sup>#</sup></li>
<li><a href="/wiki/Vincristine" title="Vincristine">Vincristine</a><sup>#</sup></li>
<li><a href="/wiki/Vinflunine" title="Vinflunine">Vinflunine</a><sup>§</sup></li>
<li><a href="/wiki/Vindesine" title="Vindesine">Vindesine</a></li>
<li><a href="/wiki/Vinorelbine" title="Vinorelbine">Vinorelbine</a>)</li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">Block microtubule disassembly</th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><i><a href="/wiki/Taxane" title="Taxane">Taxanes</a></i> (<a href="/wiki/Cabazitaxel" title="Cabazitaxel">Cabazitaxel</a></li>
<li><a href="/wiki/Docetaxel" title="Docetaxel">Docetaxel</a><sup>#</sup></li>
<li><a href="/wiki/Larotaxel" title="Larotaxel">Larotaxel</a></li>
<li><a href="/wiki/Ortataxel" title="Ortataxel">Ortataxel</a><sup>†</sup></li>
<li><a href="/wiki/Paclitaxel" title="Paclitaxel">Paclitaxel</a><sup>#</sup></li>
<li><a href="/wiki/Tesetaxel" title="Tesetaxel">Tesetaxel</a>)</li>
<li><i><a href="/wiki/Epothilone" title="Epothilone">Epothilones</a></i> (<a href="/wiki/Ixabepilone" title="Ixabepilone">Ixabepilone</a>)</li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/DNA_replication" title="DNA replication">DNA replication</a><br />
inhibitor</th>
<td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em"></div>
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th scope="row" class="navbox-group">DNA precursors/<br />
<a href="/wiki/Antimetabolite" title="Antimetabolite">antimetabolites</a><br />
(<a href="/wiki/S_phase" title="S phase">S phase</a>)</th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em"></div>
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Antifolate" title="Antifolate">Folic acid</a></th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><i><a href="/wiki/Dihydrofolate_reductase_inhibitor" title="Dihydrofolate reductase inhibitor">Dihydrofolate reductase inhibitor</a></i> (<a href="/wiki/Aminopterin" title="Aminopterin">Aminopterin</a></li>
<li><a href="/wiki/Methotrexate" title="Methotrexate">Methotrexate</a><sup>#</sup></li>
<li><a href="/wiki/Pemetrexed" title="Pemetrexed">Pemetrexed</a></li>
<li><a href="/wiki/Pralatrexate" title="Pralatrexate">Pralatrexate</a>)</li>
<li><i><a href="/wiki/Thymidylate_synthase_inhibitor" title="Thymidylate synthase inhibitor">Thymidylate synthase inhibitor</a></i> (<a href="/wiki/Raltitrexed" title="Raltitrexed">Raltitrexed</a></li>
<li><a href="/wiki/Pemetrexed" title="Pemetrexed">Pemetrexed</a>)</li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Purine_analogue" title="Purine analogue">Purine</a></th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><i><a href="/wiki/Adenosine_deaminase_inhibitor" title="Adenosine deaminase inhibitor" class="mw-redirect">Adenosine deaminase inhibitor</a></i> (<a href="/wiki/Pentostatin" title="Pentostatin">Pentostatin</a>)</li>
</ul>
<ul>
<li><i><a href="/wiki/Halogenation" title="Halogenation">Halogenated</a>/<a href="/wiki/Ribonucleotide_reductase_inhibitor" title="Ribonucleotide reductase inhibitor">ribonucleotide reductase inhibitors</a></i> (<a href="/wiki/Cladribine" title="Cladribine">Cladribine</a></li>
<li><a href="/wiki/Clofarabine" title="Clofarabine">Clofarabine</a></li>
<li><a href="/wiki/Fludarabine" title="Fludarabine">Fludarabine</a>)</li>
<li><a href="/wiki/Nelarabine" title="Nelarabine">Nelarabine</a></li>
</ul>
<ul>
<li><i><a href="/wiki/Thiopurine" title="Thiopurine">Thiopurine</a></i> (<a href="/wiki/Tioguanine" title="Tioguanine">Thioguanine</a><sup>#</sup></li>
<li><a href="/wiki/Mercaptopurine" title="Mercaptopurine">Mercaptopurine</a><sup>#</sup>)</li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Pyrimidine_analogue" title="Pyrimidine analogue">Pyrimidine</a></th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><i><a href="/wiki/Thymidylate_synthase_inhibitor" title="Thymidylate synthase inhibitor">Thymidylate synthase inhibitor</a></i> (<a href="/wiki/Fluorouracil" title="Fluorouracil">Fluorouracil</a><sup>#</sup></li>
<li><a href="/wiki/Capecitabine" title="Capecitabine">Capecitabine</a></li>
<li><a href="/wiki/Tegafur" title="Tegafur">Tegafur</a> (<a href="/wiki/Tegafur/gimeracil/oteracil" title="Tegafur/gimeracil/oteracil">+gimeracil/oteracil</a>)</li>
<li><a href="/wiki/Carmofur" title="Carmofur">Carmofur</a></li>
<li><a href="/wiki/Floxuridine" title="Floxuridine">Floxuridine</a>)</li>
</ul>
<ul>
<li><i><a href="/wiki/DNA_polymerase_inhibitor" title="DNA polymerase inhibitor" class="mw-redirect">DNA polymerase inhibitor</a></i> (<a href="/wiki/Cytarabine" title="Cytarabine">Cytarabine</a><sup>#</sup>)</li>
</ul>
<ul>
<li><i><a href="/wiki/Ribonucleotide_reductase_inhibitor" title="Ribonucleotide reductase inhibitor">Ribonucleotide reductase inhibitor</a></i> (<a href="/wiki/Gemcitabine" title="Gemcitabine">Gemcitabine</a>)</li>
</ul>
<ul>
<li><i><a href="/wiki/Hypomethylating_agent" title="Hypomethylating agent">Hypomethylating agent</a></i> (<a href="/wiki/Azacitidine" title="Azacitidine">Azacitidine</a></li>
<li><a href="/wiki/Decitabine" title="Decitabine">Decitabine</a>)</li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Deoxyribonucleotide" title="Deoxyribonucleotide">Deoxyribonucleotide</a></th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><i><a href="/wiki/Ribonucleotide_reductase_inhibitor" title="Ribonucleotide reductase inhibitor">Ribonucleotide reductase inhibitor</a></i> (<a href="/wiki/Hydroxycarbamide" title="Hydroxycarbamide">Hydroxycarbamide</a>)</li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Topoisomerase_inhibitor" title="Topoisomerase inhibitor">Topoisomerase inhibitors</a><br />
(<a href="/wiki/S_phase" title="S phase">S phase</a>)</th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em"></div>
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Type_I_topoisomerase#Inhibition" title="Type I topoisomerase">I</a></th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><i><a href="/wiki/Camptotheca" title="Camptotheca">Camptotheca</a></i> (<a href="/wiki/Camptothecin" title="Camptothecin">Camptothecin</a></li>
<li><a href="/wiki/Topotecan" title="Topotecan">Topotecan</a></li>
<li><a href="/wiki/Irinotecan" title="Irinotecan">Irinotecan</a></li>
<li><a href="/wiki/Rubitecan" title="Rubitecan">Rubitecan</a><sup>‡</sup></li>
<li><a href="/wiki/Belotecan" title="Belotecan">Belotecan</a>)</li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Type_II_topoisomerase#Inhibition" title="Type II topoisomerase">II</a></th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><i><a href="/wiki/Podophyllum_peltatum" title="Podophyllum peltatum" class="mw-redirect">Podophyllum</a></i> (<a href="/wiki/Etoposide" title="Etoposide">Etoposide</a><sup>#</sup></li>
<li><a href="/wiki/Teniposide" title="Teniposide">Teniposide</a>)</li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Type_II_topoisomerase#Inhibition" title="Type II topoisomerase">II</a>+<a href="/wiki/Intercalation_(chemistry)" title="Intercalation (chemistry)">Intercalation</a></th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><i><a href="/wiki/Anthracycline" title="Anthracycline">Anthracyclines</a></i> (<a href="/wiki/Aclarubicin" title="Aclarubicin">Aclarubicin</a></li>
<li><a href="/wiki/Daunorubicin" title="Daunorubicin">Daunorubicin</a><sup>#</sup></li>
<li><strong class="selflink">Doxorubicin</strong><sup>#</sup></li>
<li><a href="/wiki/Epirubicin" title="Epirubicin">Epirubicin</a></li>
<li><a href="/wiki/Idarubicin" title="Idarubicin">Idarubicin</a></li>
<li><a href="/wiki/Amrubicin" title="Amrubicin">Amrubicin</a><sup>†</sup></li>
<li><a href="/wiki/Pirarubicin" title="Pirarubicin">Pirarubicin</a></li>
<li><a href="/wiki/Valrubicin" title="Valrubicin">Valrubicin</a></li>
<li><a href="/wiki/Zorubicin" title="Zorubicin">Zorubicin</a>)</li>
<li><i><a href="/wiki/Anthraquinone" title="Anthraquinone">Anthracenediones</a></i> (<a href="/wiki/Mitoxantrone" title="Mitoxantrone">Mitoxantrone</a></li>
<li><a href="/wiki/Pixantrone" title="Pixantrone">Pixantrone</a>)</li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Crosslinking_of_DNA" title="Crosslinking of DNA">Crosslinking of DNA</a><br />
(<a href="/wiki/Cell-cycle_nonspecific_antineoplastic_agents" title="Cell-cycle nonspecific antineoplastic agents">CCNS</a>)</th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em"></div>
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Alkylating_antineoplastic_agent" title="Alkylating antineoplastic agent">Alkylating</a></th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><i><a href="/wiki/Nitrogen_mustard" title="Nitrogen mustard">Nitrogen mustards</a>:</i> <a href="/wiki/Mechlorethamine" title="Mechlorethamine" class="mw-redirect">Mechlorethamine</a></li>
<li><a href="/wiki/Cyclophosphamide" title="Cyclophosphamide">Cyclophosphamide</a><sup>#</sup> (<a href="/wiki/Ifosfamide" title="Ifosfamide">Ifosfamide</a></li>
<li><a href="/wiki/Trofosfamide" title="Trofosfamide">Trofosfamide</a>)</li>
<li><a href="/wiki/Chlorambucil" title="Chlorambucil">Chlorambucil</a><sup>#</sup> (<a href="/wiki/Melphalan" title="Melphalan">Melphalan</a></li>
<li><a href="/wiki/Prednimustine" title="Prednimustine">Prednimustine</a>)</li>
<li><a href="/wiki/Bendamustine" title="Bendamustine">Bendamustine</a></li>
<li><a href="/wiki/Uramustine" title="Uramustine">Uramustine</a></li>
<li><a href="/wiki/Estramustine" title="Estramustine">Estramustine</a></li>
</ul>
<ul>
<li><i><a href="/wiki/Nitrosourea" title="Nitrosourea">Nitrosoureas</a>:</i> <a href="/wiki/Carmustine" title="Carmustine">Carmustine</a></li>
<li><a href="/wiki/Lomustine" title="Lomustine">Lomustine</a> (<a href="/wiki/Semustine" title="Semustine">Semustine</a>)</li>
<li><a href="/wiki/Fotemustine" title="Fotemustine">Fotemustine</a></li>
<li><a href="/wiki/Nimustine" title="Nimustine">Nimustine</a></li>
<li><a href="/wiki/Ranimustine" title="Ranimustine">Ranimustine</a></li>
<li><a href="/wiki/Streptozotocin" title="Streptozotocin">Streptozocin</a></li>
</ul>
<ul>
<li><i><a href="/wiki/Alkyl_sulfonate" title="Alkyl sulfonate">Alkyl sulfonates</a>:</i> <a href="/wiki/Busulfan" title="Busulfan">Busulfan</a> (<a href="/wiki/Mannosulfan" title="Mannosulfan">Mannosulfan</a></li>
<li><a href="/wiki/Treosulfan" title="Treosulfan">Treosulfan</a>)</li>
</ul>
<ul>
<li><i><a href="/wiki/Aziridine" title="Aziridine">Aziridines</a>:</i> <a href="/wiki/Carboquone" title="Carboquone">Carboquone</a></li>
<li><a href="/wiki/ThioTEPA" title="ThioTEPA">ThioTEPA</a></li>
<li><a href="/wiki/Triaziquone" title="Triaziquone">Triaziquone</a></li>
<li><a href="/wiki/Triethylenemelamine" title="Triethylenemelamine">Triethylenemelamine</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Platinum-based_antineoplastic" title="Platinum-based antineoplastic">Platinum-based</a></th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Carboplatin" title="Carboplatin">Carboplatin</a></li>
<li><a href="/wiki/Cisplatin" title="Cisplatin">Cisplatin</a></li>
<li><a href="/wiki/Nedaplatin" title="Nedaplatin">Nedaplatin</a></li>
<li><a href="/wiki/Oxaliplatin" title="Oxaliplatin">Oxaliplatin</a></li>
<li><a href="/wiki/Satraplatin" title="Satraplatin">Satraplatin</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Alkylating_antineoplastic_agent#Nonclassical" title="Alkylating antineoplastic agent">Nonclassical</a></th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><i><a href="/wiki/Hydrazine" title="Hydrazine">Hydrazines</a></i> (<a href="/wiki/Procarbazine" title="Procarbazine">Procarbazine</a><sup>#</sup>)</li>
<li><i><a href="/wiki/Triazene" title="Triazene">Triazenes</a></i> (<a href="/wiki/Dacarbazine" title="Dacarbazine">Dacarbazine</a><sup>#</sup></li>
<li><a href="/wiki/Temozolomide" title="Temozolomide">Temozolomide</a>)</li>
<li><a href="/wiki/Altretamine" title="Altretamine">Altretamine</a></li>
<li><a href="/wiki/Mitobronitol" title="Mitobronitol">Mitobronitol</a></li>
<li><a href="/wiki/Pipobroman" title="Pipobroman">Pipobroman</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Intercalation_(chemistry)" title="Intercalation (chemistry)">Intercalation</a></th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Streptomyces" title="Streptomyces">Streptomyces</a> (<a href="/wiki/Actinomycin" title="Actinomycin" class="mw-redirect">Actinomycin</a><sup>#</sup></li>
<li><a href="/wiki/Bleomycin" title="Bleomycin">Bleomycin</a><sup>#</sup></li>
<li><a href="/wiki/Mitomycin" title="Mitomycin" class="mw-redirect">Mitomycin</a></li>
<li><a href="/wiki/Plicamycin" title="Plicamycin">Plicamycin</a>)</li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Photosensitizer" title="Photosensitizer">Photosensitizers</a>/<a href="/wiki/Photodynamic_therapy" title="Photodynamic therapy">PDT</a></th>
<td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Aminolevulinic_acid" title="Aminolevulinic acid">Aminolevulinic acid</a>&#160;/ <a href="/wiki/Methyl_aminolevulinate" title="Methyl aminolevulinate">Methyl aminolevulinate</a></li>
<li><a href="/wiki/Efaproxiral" title="Efaproxiral">Efaproxiral</a></li>
<li><i><a href="/wiki/Porphyrin" title="Porphyrin">Porphyrin derivatives</a></i> (<a href="/wiki/Porfimer_sodium" title="Porfimer sodium">Porfimer sodium</a></li>
<li><a href="/wiki/Talaporfin" title="Talaporfin">Talaporfin</a></li>
<li><a href="/wiki/Temoporfin" title="Temoporfin">Temoporfin</a></li>
<li><a href="/wiki/Verteporfin" title="Verteporfin">Verteporfin</a>)</li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">Other</th>
<td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em"></div>
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Enzyme_inhibitor" title="Enzyme inhibitor">Enzyme inhibitors</a></th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><i><a href="/wiki/Farnesyltransferase_inhibitor" title="Farnesyltransferase inhibitor">FI</a></i> (<a href="/wiki/Tipifarnib" title="Tipifarnib">Tipifarnib</a><sup>§</sup>)</li>
<li><i><a href="/wiki/Cyclin-dependent_kinase" title="Cyclin-dependent kinase">CDK</a> <a href="/wiki/Protein_kinase_inhibitor" title="Protein kinase inhibitor">inhibitors</a></i> (<a href="/wiki/Alvocidib" title="Alvocidib">Alvocidib</a><sup>†</sup></li>
<li><a href="/wiki/Seliciclib" title="Seliciclib">Seliciclib</a><sup>†</sup></li>
<li><a href="/wiki/Palbociclib" title="Palbociclib">Palbociclib</a>)</li>
<li><i><a href="/wiki/Proteasome_inhibitor" title="Proteasome inhibitor">PrI</a></i> (<a href="/wiki/Bortezomib" title="Bortezomib">Bortezomib</a></li>
<li><a href="/wiki/Carfilzomib" title="Carfilzomib">Carfilzomib</a>)</li>
<li><i><a href="/wiki/Phosphodiesterase_inhibitor" title="Phosphodiesterase inhibitor">PhI</a></i> (<a href="/wiki/Anagrelide" title="Anagrelide">Anagrelide</a>)</li>
<li><i><a href="/wiki/IMP_dehydrogenase" title="IMP dehydrogenase">IMPDI</a></i> (<a href="/wiki/Tiazofurin" title="Tiazofurin">Tiazofurin</a><sup>§</sup>)</li>
<li><i><a href="/wiki/Lipoxygenase_inhibitor" title="Lipoxygenase inhibitor" class="mw-redirect">LI</a></i> (<a href="/wiki/Masoprocol" title="Masoprocol">Masoprocol</a>)</li>
<li><i><a href="/wiki/PARP_inhibitor" title="PARP inhibitor">PARP inhibitor</a></i> (<a href="/wiki/Olaparib" title="Olaparib">Olaparib</a>)</li>
<li><i><a href="/wiki/Histone_deacetylase_inhibitor" title="Histone deacetylase inhibitor">HDAC</a></i> (<a href="/wiki/Belinostat" title="Belinostat">Belinostat</a></li>
<li><a href="/wiki/Panobinostat" title="Panobinostat">Panobinostat</a></li>
<li><a href="/wiki/Romidepsin" title="Romidepsin">Romidepsin</a></li>
<li><a href="/wiki/Vorinostat" title="Vorinostat">Vorinostat</a>)</li>
<li><i><a href="/wiki/Phosphoinositide_3-kinase_inhibitor" title="Phosphoinositide 3-kinase inhibitor">PIKI</a></i> (<a href="/wiki/Idelalisib" title="Idelalisib">Idelalisib</a>)</li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Receptor_antagonist" title="Receptor antagonist">Receptor antagonists</a></th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><i><a href="/wiki/Endothelin_receptor_antagonist" title="Endothelin receptor antagonist">ERA</a></i> (<a href="/wiki/Atrasentan" title="Atrasentan">Atrasentan</a>)</li>
<li><i><a href="/wiki/Retinoid_X_receptor" title="Retinoid X receptor">Retinoid X receptor</a></i> (<a href="/wiki/Bexarotene" title="Bexarotene">Bexarotene</a>)</li>
<li><i><a href="/wiki/Sex_steroid" title="Sex steroid">Sex steroid</a></i> (<a href="/wiki/Testolactone" title="Testolactone">Testolactone</a>)</li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">Other/ungrouped</th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Amsacrine" title="Amsacrine">Amsacrine</a></li>
<li><a href="/wiki/Trabectedin" title="Trabectedin">Trabectedin</a></li>
<li><i><a href="/wiki/Retinoid" title="Retinoid">Retinoids</a></i> (<a href="/wiki/Alitretinoin" title="Alitretinoin">Alitretinoin</a></li>
<li><a href="/wiki/Tretinoin" title="Tretinoin">Tretinoin</a>)</li>
<li><a href="/wiki/Arsenic_trioxide" title="Arsenic trioxide">Arsenic trioxide</a></li>
<li><i><a href="/wiki/Asparagine" title="Asparagine">Asparagine depleters</a></i> (<a href="/wiki/Asparaginase" title="Asparaginase">Asparaginase</a><sup>#</sup>/<a href="/wiki/Pegaspargase" title="Pegaspargase">Pegaspargase</a>)</li>
<li><a href="/wiki/Celecoxib" title="Celecoxib">Celecoxib</a></li>
<li><a href="/wiki/Demecolcine" title="Demecolcine">Demecolcine</a></li>
<li><a href="/wiki/Elesclomol" title="Elesclomol">Elesclomol</a><sup>§</sup></li>
<li><a href="/wiki/Elsamitrucin" title="Elsamitrucin">Elsamitrucin</a></li>
<li><a href="/wiki/Etoglucid" title="Etoglucid">Etoglucid</a></li>
<li><a href="/wiki/Lonidamine" title="Lonidamine">Lonidamine</a></li>
<li><a href="/wiki/Lucanthone" title="Lucanthone">Lucanthone</a></li>
<li><a href="/wiki/Mitoguazone" title="Mitoguazone">Mitoguazone</a></li>
<li><a href="/wiki/Mitotane" title="Mitotane">Mitotane</a></li>
<li><a href="/wiki/Oblimersen" title="Oblimersen">Oblimersen</a><sup>†</sup></li>
<li><a href="/wiki/Omacetaxine_mepesuccinate" title="Omacetaxine mepesuccinate">Omacetaxine mepesuccinate</a></li>
<li><a href="/wiki/Eribulin" title="Eribulin">Eribulin</a></li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<td class="navbox-abovebelow" colspan="2" style="background: transparent; padding: 0px;">
<div>
<div class="hlist">
<ul>
<li><sup>#</sup><a href="/wiki/WHO_Model_List_of_Essential_Medicines" title="WHO Model List of Essential Medicines">WHO-EM</a></li>
<li><sup>‡</sup><a href="/wiki/List_of_withdrawn_drugs" title="List of withdrawn drugs">Withdrawn</a> from market</li>
<li><a href="/wiki/Clinical_trial" title="Clinical trial">Clinical trials</a>:
<ul>
<li><sup>†</sup><a href="/wiki/Clinical_trial#Phase_III" title="Clinical trial">Phase III</a></li>
<li><sup>§</sup><a href="/wiki/Clinical_trial#Phase_II" title="Clinical trial">Never to phase III</a></li>
</ul>
</li>
</ul>
</div>
</div>
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th scope="col" class="navbox-title" colspan="2">
<div class="plainlinks hlist navbar mini">
<ul>
<li class="nv-view"><a href="/wiki/Template:Neoplasia_navs" title="Template:Neoplasia navs"><span title="View this template" style=";;background:none transparent;border:none;">v</span></a></li>
<li class="nv-talk"><a href="/wiki/Template_talk:Neoplasia_navs" title="Template talk:Neoplasia navs"><span title="Discuss this template" style=";;background:none transparent;border:none;">t</span></a></li>
<li class="nv-edit"><a class="external text" href="//en.wikipedia.org/w/index.php?title=Template:Neoplasia_navs&amp;action=edit"><span title="Edit this template" style=";;background:none transparent;border:none;">e</span></a></li>
</ul>
</div>
<div style="font-size:110%">Index of <a href="/wiki/Neoplasm" title="Neoplasm">neoplasms</a> and <a href="/wiki/Cancer" title="Cancer">cancer</a></div>
</th>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">Description</th>
<td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Template:Tumor_suppressor_genes_and_oncogenes" title="Template:Tumor suppressor genes and oncogenes">Tumor suppressing and oncogenes</a></li>
<li><a href="/wiki/Template:Tumor_markers" title="Template:Tumor markers">Tumor markers</a></li>
<li><a href="/wiki/Template:Carcinogen" title="Template:Carcinogen">Carcinogen</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">Disease</th>
<td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Template:Tumors" title="Template:Tumors">Neoplasms and cancer</a></li>
<li><a href="/wiki/Template:Eponymous_medical_signs_for_oncology" title="Template:Eponymous medical signs for oncology">Symptoms and signs</a></li>
<li><a href="/wiki/Template:Paraneoplastic_syndromes" title="Template:Paraneoplastic syndromes">Paraneoplastic</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">Treatment</th>
<td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Template:Radiation_oncology" title="Template:Radiation oncology">Radiotherapy</a></li>
<li>Drugs
<ul>
<li><a href="/wiki/Template:Monoclonals_for_tumors" title="Template:Monoclonals for tumors">Immunotherapy</a></li>
<li><a href="/wiki/Template:Intracellular_chemotherapeutic_agents" title="Template:Intracellular chemotherapeutic agents">intracellular chemotherapeutics</a></li>
<li><a href="/wiki/Template:Extracellular_chemotherapeutic_agents" title="Template:Extracellular chemotherapeutic agents">extracellular chemotherapeutics</a></li>
<li><a href="/wiki/Template:Detoxifying_agents_for_antineoplastic_treatment" title="Template:Detoxifying agents for antineoplastic treatment">adjuvant detoxification</a></li>
</ul>
</li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
</table>
</td>
</tr>
</table>
<table class="navbox" style="border-spacing:0">
<tr>
<td style="padding:2px">
<table class="nowraplinks hlist navbox-inner" style="border-spacing:0;background:transparent;color:inherit">
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Help:Authority_control" title="Help:Authority control">Authority control</a></th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Integrated_Authority_File" title="Integrated Authority File">GND</a>: <span class="uid"><a rel="nofollow" class="external text" href="http://d-nb.info/gnd/4150505-0">4150505-0</a></span></li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
</table>


<!-- 
NewPP limit report
Parsed by mw1009
CPU time usage: 0.960 seconds
Real time usage: 1.104 seconds
Preprocessor visited node count: 5463/1000000
Preprocessor generated node count: 0/1500000
Post‐expand include size: 228319/2097152 bytes
Template argument size: 6287/2097152 bytes
Highest expansion depth: 20/40
Expensive parser function count: 1/500
Lua time usage: 0.376/10.000 seconds
Lua memory usage: 4.58 MB/50 MB
-->

<!-- 
Transclusion expansion time report (%,ms,calls,template)
100.00%  869.546      1 - -total
 46.07%  400.619      3 - Template:Infobox
 41.92%  364.529      1 - Template:Drugbox
 31.29%  272.110      1 - Template:Reflist
 14.95%  129.992     26 - Template:Cite_journal
 11.76%  102.287      8 - Template:Navbox
  7.25%   63.040      1 - Template:Chemotherapeutic_Agents
  5.74%   49.939      1 - Template:Authority_control
  5.27%   45.813     11 - Template:Cite_web
  4.51%   39.259      1 - Template:Good_article
-->

<!-- Saved in parser cache with key enwiki:pcache:idhash:1802881-0!*!0!!en!4!* and timestamp 20150706195411 and revision id 669020725
 -->
<noscript><img src="//en.wikipedia.org/wiki/Special:CentralAutoLogin/start?type=1x1" alt="" title="" width="1" height="1" style="border: none; position: absolute;" /></noscript></div>					<div class="printfooter">
						Retrieved from "<a dir="ltr" href="https://en.wikipedia.org/w/index.php?title=Doxorubicin&amp;oldid=669020725">https://en.wikipedia.org/w/index.php?title=Doxorubicin&amp;oldid=669020725</a>"					</div>
				<div id='catlinks' class='catlinks'><div id="mw-normal-catlinks" class="mw-normal-catlinks"><a href="/wiki/Help:Category" title="Help:Category">Categories</a>: <ul><li><a href="/wiki/Category:Anthracyclines" title="Category:Anthracyclines">Anthracyclines</a></li><li><a href="/wiki/Category:Anthraquinone_glycosides" title="Category:Anthraquinone glycosides">Anthraquinone glycosides</a></li><li><a href="/wiki/Category:Topoisomerase_inhibitors" title="Category:Topoisomerase inhibitors">Topoisomerase inhibitors</a></li><li><a href="/wiki/Category:IARC_Group_2A_carcinogens" title="Category:IARC Group 2A carcinogens">IARC Group 2A carcinogens</a></li><li><a href="/wiki/Category:Embryotoxins" title="Category:Embryotoxins">Embryotoxins</a></li><li><a href="/wiki/Category:Teratogens" title="Category:Teratogens">Teratogens</a></li></ul></div><div id="mw-hidden-catlinks" class="mw-hidden-catlinks mw-hidden-cats-hidden">Hidden categories: <ul><li><a href="/wiki/Category:CS1_maint:_Explicit_use_of_et_al." title="Category:CS1 maint: Explicit use of et al.">CS1 maint: Explicit use of et al.</a></li><li><a href="/wiki/Category:Articles_with_changed_EBI_identifier" title="Category:Articles with changed EBI identifier">Articles with changed EBI identifier</a></li><li><a href="/wiki/Category:Chemical_articles_having_calculated_molecular_weight_overwritten" title="Category:Chemical articles having calculated molecular weight overwritten">Chemical articles having calculated molecular weight overwritten</a></li><li><a href="/wiki/Category:Articles_with_changed_InChI_identifier" title="Category:Articles with changed InChI identifier">Articles with changed InChI identifier</a></li><li><a href="/wiki/Category:Drugboxes_which_contain_changes_to_verified_fields" title="Category:Drugboxes which contain changes to verified fields">Drugboxes which contain changes to verified fields</a></li><li><a href="/wiki/Category:Articles_that_use_a_Medicine_navs_subtemplate" title="Category:Articles that use a Medicine navs subtemplate">Articles that use a Medicine navs subtemplate</a></li><li><a href="/wiki/Category:Good_articles" title="Category:Good articles">Good articles</a></li><li><a href="/wiki/Category:Wikipedia_articles_with_GND_identifiers" title="Category:Wikipedia articles with GND identifiers">Wikipedia articles with GND identifiers</a></li></ul></div></div>				<div class="visualClear"></div>
							</div>
		</div>
		<div id="mw-navigation">
			<h2>Navigation menu</h2>

			<div id="mw-head">
									<div id="p-personal" role="navigation" class="" aria-labelledby="p-personal-label">
						<h3 id="p-personal-label">Personal tools</h3>
						<ul>
							<li id="pt-createaccount"><a href="/w/index.php?title=Special:UserLogin&amp;returnto=Doxorubicin&amp;type=signup" title="You are encouraged to create an account and log in; however, it is not mandatory">Create account</a></li><li id="pt-login"><a href="/w/index.php?title=Special:UserLogin&amp;returnto=Doxorubicin" title="You're encouraged to log in; however, it's not mandatory. [o]" accesskey="o">Log in</a></li>						</ul>
					</div>
									<div id="left-navigation">
										<div id="p-namespaces" role="navigation" class="vectorTabs" aria-labelledby="p-namespaces-label">
						<h3 id="p-namespaces-label">Namespaces</h3>
						<ul>
															<li  id="ca-nstab-main" class="selected"><span><a href="/wiki/Doxorubicin"  title="View the content page [c]" accesskey="c">Article</a></span></li>
															<li  id="ca-talk"><span><a href="/wiki/Talk:Doxorubicin"  title="Discussion about the content page [t]" accesskey="t" rel="discussion">Talk</a></span></li>
													</ul>
					</div>
										<div id="p-variants" role="navigation" class="vectorMenu emptyPortlet" aria-labelledby="p-variants-label">
												<h3 id="p-variants-label">
							<span>Variants</span><a href="#"></a>
						</h3>

						<div class="menu">
							<ul>
															</ul>
						</div>
					</div>
									</div>
				<div id="right-navigation">
										<div id="p-views" role="navigation" class="vectorTabs" aria-labelledby="p-views-label">
						<h3 id="p-views-label">Views</h3>
						<ul>
															<li id="ca-view" class="selected"><span><a href="/wiki/Doxorubicin" >Read</a></span></li>
															<li id="ca-edit"><span><a href="/w/index.php?title=Doxorubicin&amp;action=edit"  title="Edit this page [e]" accesskey="e">Edit</a></span></li>
															<li id="ca-history" class="collapsible"><span><a href="/w/index.php?title=Doxorubicin&amp;action=history"  title="Past versions of this page [h]" accesskey="h">View history</a></span></li>
													</ul>
					</div>
										<div id="p-cactions" role="navigation" class="vectorMenu emptyPortlet" aria-labelledby="p-cactions-label">
						<h3 id="p-cactions-label"><span>More</span><a href="#"></a></h3>

						<div class="menu">
							<ul>
															</ul>
						</div>
					</div>
										<div id="p-search" role="search">
						<h3>
							<label for="searchInput">Search</label>
						</h3>

						<form action="/w/index.php" id="searchform">
							<div id="simpleSearch">
							<input type="search" name="search" placeholder="Search" title="Search Wikipedia [f]" accesskey="f" id="searchInput" /><input type="hidden" value="Special:Search" name="title" /><input type="submit" name="fulltext" value="Search" title="Search Wikipedia for this text" id="mw-searchButton" class="searchButton mw-fallbackSearchButton" /><input type="submit" name="go" value="Go" title="Go to a page with this exact name if one exists" id="searchButton" class="searchButton" />							</div>
						</form>
					</div>
									</div>
			</div>
			<div id="mw-panel">
				<div id="p-logo" role="banner"><a class="mw-wiki-logo" href="/wiki/Main_Page"  title="Visit the main page"></a></div>
						<div class="portal" role="navigation" id='p-navigation' aria-labelledby='p-navigation-label'>
			<h3 id='p-navigation-label'>Navigation</h3>

			<div class="body">
									<ul>
						<li id="n-mainpage-description"><a href="/wiki/Main_Page" title="Visit the main page [z]" accesskey="z">Main page</a></li><li id="n-contents"><a href="/wiki/Portal:Contents" title="Guides to browsing Wikipedia">Contents</a></li><li id="n-featuredcontent"><a href="/wiki/Portal:Featured_content" title="Featured content – the best of Wikipedia">Featured content</a></li><li id="n-currentevents"><a href="/wiki/Portal:Current_events" title="Find background information on current events">Current events</a></li><li id="n-randompage"><a href="/wiki/Special:Random" title="Load a random article [x]" accesskey="x">Random article</a></li><li id="n-sitesupport"><a href="https://donate.wikimedia.org/wiki/Special:FundraiserRedirector?utm_source=donate&amp;utm_medium=sidebar&amp;utm_campaign=C13_en.wikipedia.org&amp;uselang=en" title="Support us">Donate to Wikipedia</a></li><li id="n-shoplink"><a href="//shop.wikimedia.org" title="Visit the Wikimedia Shop">Wikipedia store</a></li>					</ul>
							</div>
		</div>
			<div class="portal" role="navigation" id='p-interaction' aria-labelledby='p-interaction-label'>
			<h3 id='p-interaction-label'>Interaction</h3>

			<div class="body">
									<ul>
						<li id="n-help"><a href="/wiki/Help:Contents" title="Guidance on how to use and edit Wikipedia">Help</a></li><li id="n-aboutsite"><a href="/wiki/Wikipedia:About" title="Find out about Wikipedia">About Wikipedia</a></li><li id="n-portal"><a href="/wiki/Wikipedia:Community_portal" title="About the project, what you can do, where to find things">Community portal</a></li><li id="n-recentchanges"><a href="/wiki/Special:RecentChanges" title="A list of recent changes in the wiki [r]" accesskey="r">Recent changes</a></li><li id="n-contactpage"><a href="//en.wikipedia.org/wiki/Wikipedia:Contact_us">Contact page</a></li>					</ul>
							</div>
		</div>
			<div class="portal" role="navigation" id='p-tb' aria-labelledby='p-tb-label'>
			<h3 id='p-tb-label'>Tools</h3>

			<div class="body">
									<ul>
						<li id="t-whatlinkshere"><a href="/wiki/Special:WhatLinksHere/Doxorubicin" title="List of all English Wikipedia pages containing links to this page [j]" accesskey="j">What links here</a></li><li id="t-recentchangeslinked"><a href="/wiki/Special:RecentChangesLinked/Doxorubicin" title="Recent changes in pages linked from this page [k]" accesskey="k">Related changes</a></li><li id="t-upload"><a href="/wiki/Wikipedia:File_Upload_Wizard" title="Upload files [u]" accesskey="u">Upload file</a></li><li id="t-specialpages"><a href="/wiki/Special:SpecialPages" title="A list of all special pages [q]" accesskey="q">Special pages</a></li><li id="t-permalink"><a href="/w/index.php?title=Doxorubicin&amp;oldid=669020725" title="Permanent link to this revision of the page">Permanent link</a></li><li id="t-info"><a href="/w/index.php?title=Doxorubicin&amp;action=info" title="More information about this page">Page information</a></li><li id="t-wikibase"><a href="//www.wikidata.org/wiki/Q18936" title="Link to connected data repository item [g]" accesskey="g">Wikidata item</a></li><li id="t-cite"><a href="/w/index.php?title=Special:CiteThisPage&amp;page=Doxorubicin&amp;id=669020725" title="Information on how to cite this page">Cite this page</a></li>					</ul>
							</div>
		</div>
			<div class="portal" role="navigation" id='p-coll-print_export' aria-labelledby='p-coll-print_export-label'>
			<h3 id='p-coll-print_export-label'>Print/export</h3>

			<div class="body">
									<ul>
						<li id="coll-create_a_book"><a href="/w/index.php?title=Special:Book&amp;bookcmd=book_creator&amp;referer=Doxorubicin">Create a book</a></li><li id="coll-download-as-rdf2latex"><a href="/w/index.php?title=Special:Book&amp;bookcmd=render_article&amp;arttitle=Doxorubicin&amp;oldid=669020725&amp;writer=rdf2latex">Download as PDF</a></li><li id="t-print"><a href="/w/index.php?title=Doxorubicin&amp;printable=yes" title="Printable version of this page [p]" accesskey="p">Printable version</a></li>					</ul>
							</div>
		</div>
			<div class="portal" role="navigation" id='p-lang' aria-labelledby='p-lang-label'>
			<h3 id='p-lang-label'>Languages</h3>

			<div class="body">
									<ul>
						<li class="interlanguage-link interwiki-ar"><a href="//ar.wikipedia.org/wiki/%D8%AF%D9%88%D9%83%D8%B3%D9%88%D8%B1%D9%88%D8%A8%D9%8A%D8%B3%D9%8A%D9%86" title="دوكسوروبيسين – Arabic" lang="ar" hreflang="ar">العربية</a></li><li class="interlanguage-link interwiki-ca"><a href="//ca.wikipedia.org/wiki/Doxorrubicina" title="Doxorrubicina – Catalan" lang="ca" hreflang="ca">Català</a></li><li class="interlanguage-link interwiki-de"><a href="//de.wikipedia.org/wiki/Doxorubicin" title="Doxorubicin – German" lang="de" hreflang="de">Deutsch</a></li><li class="interlanguage-link interwiki-es"><a href="//es.wikipedia.org/wiki/Doxorrubicina" title="Doxorrubicina – Spanish" lang="es" hreflang="es">Español</a></li><li class="interlanguage-link interwiki-fa"><a href="//fa.wikipedia.org/wiki/%D8%AF%D9%88%DA%A9%D8%B3%D9%88%D8%B1%D8%A7%D8%A8%DB%8C%D8%B3%DB%8C%D9%86" title="دوکسورابیسین – Persian" lang="fa" hreflang="fa">فارسی</a></li><li class="interlanguage-link interwiki-fr"><a href="//fr.wikipedia.org/wiki/Doxorubicine" title="Doxorubicine – French" lang="fr" hreflang="fr">Français</a></li><li class="interlanguage-link interwiki-gl"><a href="//gl.wikipedia.org/wiki/Doxorrubicina" title="Doxorrubicina – Galician" lang="gl" hreflang="gl">Galego</a></li><li class="interlanguage-link interwiki-it"><a href="//it.wikipedia.org/wiki/Doxorubicina" title="Doxorubicina – Italian" lang="it" hreflang="it">Italiano</a></li><li class="interlanguage-link interwiki-hu"><a href="//hu.wikipedia.org/wiki/Doxorubicin" title="Doxorubicin – Hungarian" lang="hu" hreflang="hu">Magyar</a></li><li class="interlanguage-link interwiki-nl"><a href="//nl.wikipedia.org/wiki/Doxorubicine" title="Doxorubicine – Dutch" lang="nl" hreflang="nl">Nederlands</a></li><li class="interlanguage-link interwiki-ja"><a href="//ja.wikipedia.org/wiki/%E3%83%89%E3%82%AD%E3%82%BD%E3%83%AB%E3%83%93%E3%82%B7%E3%83%B3" title="ドキソルビシン – Japanese" lang="ja" hreflang="ja">日本語</a></li><li class="interlanguage-link interwiki-pl"><a href="//pl.wikipedia.org/wiki/Doksorubicyna" title="Doksorubicyna – Polish" lang="pl" hreflang="pl">Polski</a></li><li class="interlanguage-link interwiki-pt"><a href="//pt.wikipedia.org/wiki/Doxorrubicina" title="Doxorrubicina – Portuguese" lang="pt" hreflang="pt">Português</a></li><li class="interlanguage-link interwiki-ru"><a href="//ru.wikipedia.org/wiki/%D0%94%D0%BE%D0%BA%D1%81%D0%BE%D1%80%D1%83%D0%B1%D0%B8%D1%86%D0%B8%D0%BD" title="Доксорубицин – Russian" lang="ru" hreflang="ru">Русский</a></li><li class="interlanguage-link interwiki-sr"><a href="//sr.wikipedia.org/wiki/Doksorubicin" title="Doksorubicin – Serbian" lang="sr" hreflang="sr">Српски / srpski</a></li><li class="interlanguage-link interwiki-sh"><a href="//sh.wikipedia.org/wiki/Doksorubicin" title="Doksorubicin – Serbo-Croatian" lang="sh" hreflang="sh">Srpskohrvatski / српскохрватски</a></li><li class="interlanguage-link interwiki-fi"><a href="//fi.wikipedia.org/wiki/Doksorubisiini" title="Doksorubisiini – Finnish" lang="fi" hreflang="fi">Suomi</a></li><li class="interlanguage-link interwiki-tl"><a href="//tl.wikipedia.org/wiki/Doxorubicin" title="Doxorubicin – Tagalog" lang="tl" hreflang="tl">Tagalog</a></li><li class="interlanguage-link interwiki-tr"><a href="//tr.wikipedia.org/wiki/Doksorubisin" title="Doksorubisin – Turkish" lang="tr" hreflang="tr">Türkçe</a></li><li class="interlanguage-link interwiki-uk"><a href="//uk.wikipedia.org/wiki/%D0%94%D0%BE%D0%BA%D1%81%D0%BE%D1%80%D1%83%D0%B1%D1%96%D1%86%D0%B8%D0%BD" title="Доксорубіцин – Ukrainian" lang="uk" hreflang="uk">Українська</a></li><li class="interlanguage-link interwiki-zh"><a href="//zh.wikipedia.org/wiki/%E9%98%BF%E9%BB%B4%E7%B4%A0" title="阿黴素 – Chinese" lang="zh" hreflang="zh">中文</a></li><li class="uls-p-lang-dummy"><a href="#"></a></li>					</ul>
				<div class='after-portlet after-portlet-lang'><span class="wb-langlinks-edit wb-langlinks-link"><a href="//www.wikidata.org/wiki/Q18936#sitelinks-wikipedia" title="Edit interlanguage links" class="wbc-editpage">Edit links</a></span></div>			</div>
		</div>
				</div>
		</div>
		<div id="footer" role="contentinfo">
							<ul id="footer-info">
											<li id="footer-info-lastmod"> This page was last modified on 28 June 2015, at 09:49.</li>
											<li id="footer-info-copyright">Text is available under the <a rel="license" href="//en.wikipedia.org/wiki/Wikipedia:Text_of_Creative_Commons_Attribution-ShareAlike_3.0_Unported_License">Creative Commons Attribution-ShareAlike License</a><a rel="license" href="//creativecommons.org/licenses/by-sa/3.0/" style="display:none;"></a>;
additional terms may apply.  By using this site, you agree to the <a href="//wikimediafoundation.org/wiki/Terms_of_Use">Terms of Use</a> and <a href="//wikimediafoundation.org/wiki/Privacy_policy">Privacy Policy</a>. Wikipedia® is a registered trademark of the <a href="//www.wikimediafoundation.org/">Wikimedia Foundation, Inc.</a>, a non-profit organization.</li>
									</ul>
							<ul id="footer-places">
											<li id="footer-places-privacy"><a href="//wikimediafoundation.org/wiki/Privacy_policy" title="wikimedia:Privacy policy">Privacy policy</a></li>
											<li id="footer-places-about"><a href="/wiki/Wikipedia:About" title="Wikipedia:About">About Wikipedia</a></li>
											<li id="footer-places-disclaimer"><a href="/wiki/Wikipedia:General_disclaimer" title="Wikipedia:General disclaimer">Disclaimers</a></li>
											<li id="footer-places-contact"><a href="//en.wikipedia.org/wiki/Wikipedia:Contact_us">Contact Wikipedia</a></li>
											<li id="footer-places-developers"><a href="https://www.mediawiki.org/wiki/Special:MyLanguage/How_to_contribute">Developers</a></li>
											<li id="footer-places-mobileview"><a href="//en.m.wikipedia.org/w/index.php?title=Doxorubicin&amp;mobileaction=toggle_view_mobile" class="noprint stopMobileRedirectToggle">Mobile view</a></li>
									</ul>
										<ul id="footer-icons" class="noprint">
											<li id="footer-copyrightico">
							<a href="//wikimediafoundation.org/"><img src="/static/images/wikimedia-button.png" srcset="/static/images/wikimedia-button-1.5x.png 1.5x, /static/images/wikimedia-button-2x.png 2x" width="88" height="31" alt="Wikimedia Foundation"/></a>						</li>
											<li id="footer-poweredbyico">
							<a href="//www.mediawiki.org/"><img src="//en.wikipedia.org/static/1.26wmf13/resources/assets/poweredby_mediawiki_88x31.png" alt="Powered by MediaWiki" srcset="//en.wikipedia.org/static/1.26wmf13/resources/assets/poweredby_mediawiki_132x47.png 1.5x, //en.wikipedia.org/static/1.26wmf13/resources/assets/poweredby_mediawiki_176x62.png 2x" width="88" height="31" /></a>						</li>
									</ul>
						<div style="clear:both"></div>
		</div>
		<script>if(window.jQuery)jQuery.ready();</script><script>if(window.mw){
mw.loader.state({"ext.globalCssJs.site":"ready","ext.globalCssJs.user":"ready","site":"loading","user":"ready","user.groups":"ready"});
}</script>
<link rel="stylesheet" href="//en.wikipedia.org/w/load.php?debug=false&amp;lang=en&amp;modules=ext.cite.styles%7Cext.gadget.DRN-wizard%2CReferenceTooltips%2CWatchlistGreenIndicators%2Ccharinsert%2Cfeatured-articles-links%2CrefToolbar%2Cswitcher%2Cteahouse%7Cext.wikimediaBadges&amp;only=styles&amp;skin=vector&amp;*" />
<script>if(window.mw){
mw.loader.load(["ext.cite.a11y","mediawiki.toc","mediawiki.action.view.postEdit","mediawiki.user","mediawiki.hidpi","mediawiki.page.ready","mediawiki.searchSuggest","ext.cirrusSearch.loggingSchema","mmv.bootstrap.autostart","ext.imageMetrics.loader","ext.eventLogging.subscriber","ext.wikimediaEvents","ext.wikimediaEvents.statsd","ext.navigationTiming","ext.gadget.teahouse","ext.gadget.ReferenceTooltips","ext.gadget.WatchlistGreenIndicators","ext.gadget.DRN-wizard","ext.gadget.charinsert","ext.gadget.refToolbar","ext.gadget.switcher","ext.gadget.featured-articles-links","ext.visualEditor.targetLoader","schema.UniversalLanguageSelector","ext.uls.eventlogger","ext.uls.interlanguage"],null,true);
}</script>
<script>if(window.mw){
document.write("\u003Cscript src=\"//en.wikipedia.org/w/load.php?debug=false\u0026amp;lang=en\u0026amp;modules=site\u0026amp;only=scripts\u0026amp;skin=vector\u0026amp;*\"\u003E\u003C/script\u003E");
}</script>
<script>if(window.mw){
mw.config.set({"wgBackendResponseTime":99,"wgHostname":"mw1163"});
}</script>
	</body>
</html>
